<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2021.668670</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Axotomy Induces Drp1-Dependent Fragmentation of Axonal Mitochondria</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kedra</surname> <given-names>Joseph</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lin</surname> <given-names>Shen</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1279957/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Pacheco</surname> <given-names>Almudena</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gallo</surname> <given-names>Gianluca</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref>
</contrib> 
<contrib contrib-type="author" corresp="yes">
<name><surname>Smith</surname> <given-names>George M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/123948/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine, Temple University</institution>, <addr-line>Philadelphia, PA</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Anatomy and Cell Biology, Lewis Katz School of Medicine, Temple University</institution>, <addr-line>Philadelphia, PA</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Neuroscience, Lewis Katz School of Medicine, Temple University</institution>, <addr-line>Philadelphia, PA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Dianna E. Willis, Burke-Cornell Medical Research Institute, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Yongcheol Cho, Korea University, South Korea; Woong Sun, Korea University, South Korea</p></fn>
<corresp id="c001">&#x0002A;Correspondence: George M. Smith <email>george.smith&#x00040;temple.edu</email></corresp>
<fn fn-type="other" id="fn001"><p><sup>&#x02020;</sup>These authors have contributed equally to this work and share senior authorship</p></fn>
<fn fn-type="other" id="fn002"><p><bold>Specialty section</bold>: This article was submitted to Molecular Signalling and Pathways, a section of the journal Frontiers in Molecular Neuroscience</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>14</volume>
<elocation-id>668670</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>02</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>05</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2021 Kedra, Lin, Pacheco, Gallo and Smith.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Kedra, Lin, Pacheco, Gallo and Smith</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract><p>It is well established that CNS axons fail to regenerate, undergo retrograde dieback, and form dystrophic growth cones due to both intrinsic and extrinsic factors. We sought to investigate the role of axonal mitochondria in the axonal response to injury. A viral vector (AAV) containing a mitochondrially targeted fluorescent protein (mitoDsRed) as well as fluorescently tagged LC3 (GFP-LC3), an autophagosomal marker, was injected into the primary motor cortex, to label the corticospinal tract (CST), of adult rats. The axons of the CST were then injured by dorsal column lesion at C4-C5. We found that mitochondria in injured CST axons near the injury site are fragmented and fragmentation of mitochondria persists for 2 weeks before returning to pre-injury lengths. Fragmented mitochondria have consistently been shown to be dysfunctional and detrimental to cellular health. Inhibition of Drp1, the GTPase responsible for mitochondrial fission, using a specific pharmacological inhibitor (mDivi-1) blocked fragmentation. Additionally, it was determined that there is increased mitophagy in CST axons following Spinal cord injury (SCI) based on increased colocalization of mitochondria and LC3. <italic>In vitro</italic> models revealed that mitochondrial divalent ion uptake is necessary for injury-induced mitochondrial fission, as inhibiting the mitochondrial calcium uniporter (MCU) using RU360 prevented injury-induced fission. This phenomenon was also observed <italic>in vivo</italic>. These studies indicate that following the injury, both <italic>in vivo</italic> and <italic>in vitro</italic>, axonal mitochondria undergo increased fission, which may contribute to the lack of regeneration seen in CNS neurons.</p></abstract>
<kwd-group>
<kwd>regeneration</kwd>
<kwd>mitochondria</kwd>
<kwd>mitophagy</kwd>
<kwd>corticospinal tract (CST)</kwd>
<kwd>spinal cord injury</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="91"/>
<page-count count="17"/>
<word-count count="11624"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction" id="s1">
<title>Introduction</title>
<p>Spinal cord injury (SCI) is a severe medical problem with high mortality and long-term morbidity (Eckert and Martin, <xref ref-type="bibr" rid="B21">2017</xref>) for which there is no effective treatment. Following injury, severed axons often undergo dieback/retraction from the site of injury and fail to exhibit subsequent regeneration up to and beyond the injury site. Additionally, many severed axons within the CNS form retraction bulbs at the cut axon tip as opposed to new growth cones (Hill et al., <xref ref-type="bibr" rid="B34">2001</xref>; Hill, <xref ref-type="bibr" rid="B33">2017</xref>). Regenerative failure is due to cell intrinsic (Fawcett and Verhaagen, <xref ref-type="bibr" rid="B22">2018</xref>) and extrinsic factors (Fitch and Silver, <xref ref-type="bibr" rid="B23">2008</xref>). For functional regeneration and repair of injured circuitry to occur, it will be necessary to manipulate both intrinsic and extrinsic factors. Herein, we focus on elucidating the intrinsic factors that impair axon regeneration, specifically focusing on the mitochondrial response to axonal injury in the severed axon.</p>
<p>The mitochondrion has multiple functions in the regulation of cellular physiology by generating ATP, buffering cytosolic calcium, and when dysfunctional, generating excessive reactive oxygen species (ROS; Kasahara and Scorrano, <xref ref-type="bibr" rid="B41">2014</xref>; Brennan-Minnella et al., <xref ref-type="bibr" rid="B11">2016</xref>; Fonteriz et al., <xref ref-type="bibr" rid="B24">2016</xref>; Islam, <xref ref-type="bibr" rid="B37">2017</xref>). In neurons, mitochondria are highly dynamic (Saxton and Hollenbeck, <xref ref-type="bibr" rid="B72">2012</xref>; Schwarz, <xref ref-type="bibr" rid="B73">2013</xref>; Sheng, <xref ref-type="bibr" rid="B75">2014</xref>; Barnhart, <xref ref-type="bibr" rid="B6">2016</xref>). They undergo regulated fission and fusion to adjust their distribution and physiological functions, and if dysfunctional are fragmented by excessive fission before removal by mitophagy. Mitochondria also determine sites of axonal branching and provide important functions in axonal regeneration (Courchet et al., <xref ref-type="bibr" rid="B20">2013</xref>; Spillane et al., <xref ref-type="bibr" rid="B77">2013</xref>; Tao et al., <xref ref-type="bibr" rid="B80">2014</xref>; Cartoni et al., <xref ref-type="bibr" rid="B13">2016</xref>; Han et al., <xref ref-type="bibr" rid="B31">2016</xref>; Winkle et al., <xref ref-type="bibr" rid="B84">2016</xref>; Zhou et al., <xref ref-type="bibr" rid="B88">2016</xref>; Sainath et al., <xref ref-type="bibr" rid="B71">2017</xref>). It is well established that neuronal mitochondria are adversely affected in a variety of neurodegenerative disorders (Abeti and Abramov, <xref ref-type="bibr" rid="B1">2015</xref>; Lane et al., <xref ref-type="bibr" rid="B49">2015</xref>; Zhang et al., <xref ref-type="bibr" rid="B87">2015</xref>; Arun et al., <xref ref-type="bibr" rid="B3">2016</xref>; Bertholet et al., <xref ref-type="bibr" rid="B8">2016</xref>; Krols et al., <xref ref-type="bibr" rid="B46">2016</xref>; Golpich et al., <xref ref-type="bibr" rid="B29">2017</xref>) and following spinal cord injury at the level of whole tissue (Jin et al., <xref ref-type="bibr" rid="B38">2004</xref>; McEwen et al., <xref ref-type="bibr" rid="B55">2007</xref>; Sullivan et al., <xref ref-type="bibr" rid="B79">2007</xref>; Patel et al., <xref ref-type="bibr" rid="B63">2009</xref>, <xref ref-type="bibr" rid="B62">2010</xref>). However, the response of axonal mitochondria to spinal cord injury is yet to be fully understood. The primary features of mitochondrial dysfunction are the fragmentation of mitochondria through repeated bouts of fission into small submicron particles and the concurrent loss of the mitochondrial membrane potential resulting in ATP depletion and generation of ROS. The GTPase Dynamin-related protein 1 (Drp1) is the primary mediator of normal physiological mitochondrial fission, as well as excessive fission leading to fragmentation (Kageyama et al., <xref ref-type="bibr" rid="B39">2011</xref>; Cho et al., <xref ref-type="bibr" rid="B18">2013</xref>; Otera et al., <xref ref-type="bibr" rid="B60">2013</xref>; Sesaki et al., <xref ref-type="bibr" rid="B74">2014</xref>). Mitophagy, a mitochondria selective form of autophagy, serves as a protective mechanism to remove fragmented dysfunctional mitochondria in cells (Karbowski, <xref ref-type="bibr" rid="B40">2010</xref>; Ashrafi and Schwarz, <xref ref-type="bibr" rid="B4">2013</xref>; Balog et al., <xref ref-type="bibr" rid="B5">2016</xref>).</p>
<p>We report that following spinal cord injury, there is a rapid fragmentation of mitochondria in corticospinal tract (CST) axons that persists for up to 3 days following injury before recovery of normal mitochondrial size begins, ultimately attaining sizes similar to uninjured axonal mitochondria 2 weeks after injury. The injury-induced mitochondrial fragmentation requires Drp1 and coincides with an increase in mitophagy that follows a temporal pattern similar to fragmentation. We developed <italic>in vitro</italic> model systems of axonal injury that mimic the <italic>in vivo</italic> response in order to address the injury-induced fission of mitochondria with high spatiotemporal resolution. Using these <italic>in vitro</italic> systems, we find that mitochondrial calcium uptake is required for injury-induced mitochondrial fission, a finding supported by <italic>in vivo</italic> analysis of the role of mitochondria calcium uptake. These insights may pave the way for the development of new therapeutic approaches aimed at the manipulation of axonal mitochondria following injury.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Animals</title>
<p>All surgical and animal care protocols were approved by the Temple University School of Medicine&#x02019;s Institutional Animal Care and Use Committee and performed per the National Institutes of Health <italic>Guide for the Care and Use of Laboratory Animals</italic>. Sprague&#x02013;Dawley rats (65&#x02013;75 days, 200&#x02013;224 g; Harlan Laboratories) were housed two per cage, on a 12 h light-dark cycle with food and water provided <italic>ad libitum</italic>. Animals were allowed 7 days of acclimatization prior to any experimental procedure. At the time of surgery, animals ranged in weight from 225 to 250 g. To prevent infection after surgery, animals received an IP injection of 0.5 ml Cefazolin (10 mg/ml). All animals received a subcutaneous injection of 2&#x02013;3 ml of 0.9% NaCl solution to prevent dehydration following surgery. Analgesia was provided by twice daily oral administration of Rimadyl tablets (1 mg) for 3 days beginning immediately postoperatively.</p>
</sec>
<sec id="s2-2">
<title>Viral Vectors</title>
<p>AAV2-GFP-P2A-mitoDsRed was generated by subcloning the mitoDsRed from the original adenovirus vector (Nasr et al., <xref ref-type="bibr" rid="B59">2008</xref>) into MluI and XhoI sites downstream of the P2A of pAM-CBA-eGFP-P2A. To generate AAV2-eGFPLC3-P2A-mitoDsRed the GFP coding region was removed from AAV2-GFP-P2A-mitoDsRed plasmid and replaced with eGFPLC3 (Addgene: &#x00023;22405). Purified AAV plasmid was packaged using the helper-free method as reported previously (Ayuso et al., <xref ref-type="bibr" rid="B100">2010</xref>; Liu et al., <xref ref-type="bibr" rid="B101">2014</xref>). In brief, HEK293T cells at 70&#x02013;80% confluency were transfected with two packaging plasmids, one carrying AAV <italic>rep</italic> and <italic>cap</italic>, the other with AAV helper functions, and the transgene using a polyethylenimine method (PEI; polyethylenimine, linear, MW 25k, Warrington, PA). Three days post transfection, cell supernatant, and lysates were harvested. 40% PEG 8000 was added to precipitate crude virus for 2 h. AAV samples were double-ultracentrifuged in a cesium chloride gradient with isolated viral fractions dialyzed in 0.1 M PBS/0.5% Sorbital overnight (Ayuso et al., <xref ref-type="bibr" rid="B100">2010</xref>; Liu et al., <xref ref-type="bibr" rid="B101">2014</xref>). Purified fractions were added to HEK293T cells to verify function. Quantitative real-time PCR of purified viral fractions was done to determine viral titer. The viral titer of AAV2 was 1.2 &#x000D7; 10<sup>13</sup> GC/ml.</p>
</sec>
<sec id="s2-3">
<title>Surgical Procedures</title>
<sec id="s2-3-1">
<title>Cortical Injections</title>
<p>Animals were anesthetized with a ketamine (67 mg/kg)/xylazine (6.7 mg/kg, i.p.) mixture. Their scalps were shaved, and the animals were placed in a stereotaxic head holder. Under aseptic conditions, a small bone flap was cut in the skull to expose the dorsal surface of the primary somatomotor cortex bilaterally. Bone flaps extended from 1 mm anterior to bregma to 1 mm posterior to bregma and from 1 mm from midline laterally to approximately 4.5 mm. Injections into the somatomotor cortex were performed using a beveled glass micropipette pulled to a diameter of 30&#x02013;40 &#x003BC;m connected to a nanoliter injector (Nanoject, Drummond Scientific). All injections were made using a stereotaxic device or micromanipulator (Narishige International) for precise measurements. All coordinates were determined in relationship to bregma. Bilateral injections of either AAV2-GFP-P2A-mitoDsRed or AAV2-GFPLC3-P2A-mitoDsRed (1.5 &#x003BC;l/injection) were made using the following coordinates: AP axis: +0.5 mm ML axis: +/&#x02212; 2.5 mm, AP axis: +0.5 mm ML axis: +/&#x02212; 3.5 mm, AP axis: &#x02212;0.5 mm ML axis: +/&#x02212; 3.0 mm, AP axis: &#x02212;0.5 mm ML axis: +/&#x02212; 4.0 mm. Coordinates were carefully identified based on the rat brain atlas (Paxinos and Charles, <xref ref-type="bibr" rid="B64">2007</xref>). Following virus injection, all animals were maintained for 4 weeks before cervical spinal cord injury was performed.</p>
</sec>
<sec id="s2-3-2">
<title>Corticospinal Tract Severing</title>
<p>Animals were anesthetized with a ketamine (67 mg/kg)/xylazine (6.7 mg/kg, i.p.) mixture. Under aseptic conditions, a 1 cm incision is made through the dorsal skin above vertebra C3-C6. The skin is retracted to expose the underlying muscle. The exposed spinotrapezius muscle is cut along the midline with scissors, then spread with a small Alm retractor. The muscles are freed from the cervical vertebrae with scissors. The first thoracic vertebrae has a very prominent dorsal spinal process for easy identification. A full laminectomy of vertebra C4 and C5 was performed, so as not to damage the spinal cord. Using micro scissors (Vannas Spring Scissors, Fine Science Tools, Inc.) the dorsal column was precisely transected bilaterally (1.5 mm width, 1.1 mm depth). The muscles overlying the spinal cord were loosely sutured together with a 5&#x02013;0 suture and the wound closed. Animals were allowed to recover at 37&#x000B0;C. Animals were maintained for either 2 h, 8 h, 1 day, 3 days, 1 week, 2 weeks, or 6 weeks following surgery.</p>
<p>For experiments involving mDivi-1 (Cat&#x00023; 338967-87-6, Sigma-Aldrich) rats had IP injections of either mDivi-1 (50 mg/kg for 250 g rats) or vehicle (10%DMSO/40% PEG300 in saline) 12 h prior to CST severing and immediately after for rats being maintained for 1 day. Rats being maintained for 6 weeks received IP injections 12 h prior to CST severing, immediately after surgery, and once per day for 7 days following the injury.</p>
</sec>
</sec>
<sec id="s2-4">
<title>Tissue Processing and Histology</title>
<p>At the completion of each experiment, all animals were euthanized by injection of Fatal-Plus (Dearborn, MI, United States) and perfused with saline (0.9% NaCl) followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (pH 7.5). The brain and spinal cord were promptly dissected. Spinal cord samples were dissected with dorsal roots intact for identification of each spinal level. Samples were post-fixed in 4% PFA overnight at 4&#x000B0;C. Tissue samples were then transferred to a series of graded sucrose (10%, 20%, and 30%) where they remained for the following 24 h or until the brain section sunk to the bottom of the container. A 3 cm section of the spinal cord with the lesion at the center was removed from the whole spinal cord. The spinal cord samples were serially sectioned, sagittally at 30 &#x003BC;m intervals using a Leica CM3050S cryostat. Sections were collected and placed into cryoprotectant solution, then stored at &#x02212;20&#x000B0;C until processed for histology.</p>
</sec>
<sec id="s2-5">
<title>Immunofluorescence</title>
<p>To amplify the GFP and DsRed signals, sections were permeabilized in 0.3% Triton X-100 with 5% normal goat serum to block non-specific binding sites. Samples were then incubated with chicken-anti-GFP primary antibody (1:1,000; &#x00023;GFP-1020; Aves Labs Inc., Tigard, OR, United States) and rabbit-anti-DsRed primary antibody (1:500; &#x00023;632496; Takara Bio USA, Inc., Mountain View, CA, United States) overnight at 4&#x000B0;C. The next day, samples were incubated with donkey-anti-chicken-AlexaFluor 488 sary antibody (1:400, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, United States) and goat-anti-rabbit-AlexaFluor 594 sary antibody (1:400, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, United States) then mounted on glass slides.</p>
</sec>
<sec id="s2-6">
<title>Tissue Section Imaging</title>
<p>Imaging was performed using AxioVision software (Carl Zeiss Microscopy, Thornwood, NY, United States). A 100&#x000D7; /1.3 N/A objective with a &#x0007E;300 nm focal plane was used to generate Z-stacks using 250 nm Z-intervals through 30 &#x003BC;m of tissue sections. In order to maximize the power of the morphological analysis, 1 &#x000D7; 1 camera binning was used to generate the highest spatial resolution in the images. Max-intensity 2D projections were then generated using sets of sections from the Z-stack that contained mitochondria.</p>
</sec>
<sec id="s2-7">
<title>Culturing of Primary Neurons</title>
<p>Chicken dorsal root ganglia (DRG) were dissected at embryonic day 7 (E7) or day 14 (E14; SPF eggs obtained from Charles River Laboratories). At this developmental stage, it is not possible to determine the sex, and both sexes were used at presumably a 50/50 ratio. Whole explants were cultured (3&#x02013;4 explants/dish), or the DRG neurons were dissociated and transfected (as explained below; 1.5 explants/dish). The culturing substrata were previously coated with polylysine [Sigma; Catalog number (Cat&#x00023;) P9011; 100 &#x003BC;g/ml in borate buffer], for 4 h and following 3&#x000D7; washing with phosphate-buffered saline (PBS) with 25 &#x003BC;g/ml laminin (Life Technologies Cat&#x00023; 23017-015) in PBS overnight, all incubations were performed at 39&#x000B0;C. Explants and dissociated neurons were cultured in a defined F12H medium (Gibco; Cat&#x00023;21700075) supplemented with NGF (20 ng/ml). For live imaging experiments, explants or dissociated neurons were plated in glass-bottom dishes.</p>
<p>For the preparation of dissociated neurons, sensory ganglia were incubated in Ca<sup>2+</sup>&#x02013;Mg<sup>2+</sup>-free PBS (CMF-PBS), for 10 min at 37&#x000B0;C. Ganglia were then spun down for 1 min, and the supernatant was removed. Ganglia were then treated with 0.25% trypsin (Fisher Scientific Cat&#x00023; MT25005CI), for 10 min at 37&#x000B0;C and spun down for 1 min. Ganglia were then pipette triturated 30 times in F12HS10 media (F12H medium supplemented with 10% fetal bovine serum: Fisher; Cat&#x00023;MT350111CV) and then spun down for 4 min. The supernatant was removed and cells were transfected as described below.</p>
<p>Rat hippocampal neurons were dissociated from dissected E18 rat hippocampi as previously described (Thomas et al., <xref ref-type="bibr" rid="B81">2012</xref>). Neurons were cultured in Neurobasal media supplemented with B27 (Thermo Fischer Scientific) in glass-bottomed dishes coated with polylysine [Sigma; Catalog number (Cat&#x00023;) P9011; 100 &#x003BC;g/ml in borate buffer] and laminin (Life Technologies Cat&#x00023; 23017-015; 25 &#x003BC;g/ml) as described above.</p>
<p>Adult rat DRG dissociated cultures were prepared as described previously (Pacheco et al., <xref ref-type="bibr" rid="B61">2020</xref>).</p>
</sec>
<sec id="s2-8">
<title>Transfection</title>
<p>For transfection of plasmids into neurons, 40 chicken DRGs were dissociated as described above, and after F12HS10 was removed neurons were suspended in 100 &#x003BC;l nucleofector solution (Lonza Cat&#x00023; VPG-1002) and gently resuspended through trituration. The DRG cell suspension was transferred to a nucleofector cuvette containing 10 &#x003BC;g of Plasmid DNA and electroporated using an Amaxa Nucleoporator (program G-13). The electroporated solution was then immediately transferred to a tube containing F12H media as described above prior to plating.</p>
</sec>
<sec id="s2-9">
<title>Labeling of Mitochondria <italic>In vitro</italic></title>
<p>For labeling mitochondria to determine mitochondrial fission rates, neurons were transfected with pDsRed2-Mito (Clontech Cat&#x00023; 632421) as explained above. To measure mitochondrial length, mitochondria were labeled with mitochondria targeted dyes, which were prepared according to the manufacturer&#x02019;s directions. Labeling was performed through incubation for 30 min with MitoTracker green (50 nM, Molecular Probes, Cat&#x00023; M7514) or Mitoview 633 (20 nM, Biotium<sup>&#x000AE;</sup>, Heyward, USA; Cat&#x00023; 70055-T). Following labeling, the dye-containing medium was removed and cultures were washed three times with culturing medium not containing any dye. Imaging was performed at least 30 min after the dye was removed to allow cultures to acclimate.</p>
</sec>
<sec id="s2-10">
<title><italic>In vitro</italic> Axonal Severing</title>
<p>For experiments in which DRG explants were used, explants were plated in glass-bottom dishes as described above and cultured for 48 h. Dishes were placed on the microscope stage for 10 min prior to severing. Axons were severed by dragging a No. 11 scalpel blade across the axon perpendicular to its direction of growth.</p>
<p>For experiments in which dissociated, transfected neurons were used, neurons were cultured in glass-bottom dishes as described above for 24 h, with the exception of neurons transfected with GCaMP6, which were cultured for 72 h (the time at which expression of GCaMP6 was optimal). Dishes were placed on the stage 10 min prior to severing. Severing was performed as previously described (Gallo, <xref ref-type="bibr" rid="B26">2004</xref>). Briefly, only axons that exhibited a &#x0201C;healthy&#x0201D; uniform caliber axon were used in single-axon-severing experiments. The severing of axons was performed approximately 200 &#x003BC;m from the axon tip. For severing, borosilicate glass capillaries (AM Systems, Carlsborg WA; catalog &#x00023; 625500) were pulled to fine tips using a Pul-1 micropipette puller (World Precision Instruments, Sarasota FL). Capillary needles were mounted on a mechanical micromanipulator (Leica Inc., Bannockburn, IL). The tip was then brought into contact with the substratum and axons severed by maintaining the position of the tip steady while moving the stage relative to the tip. The stage was moved manually in a continuous swift motion resulting in the uniform severing of axons.</p>
</sec>
<sec id="s2-11">
<title>Live Imaging</title>
<p>Neurons were imaged using a Zeiss 200 M microscope equipped with an Orca-ER camera (Hamamatsu) in series with a PC workstation running Zeiss Axiovision software for image acquisition and analysis. Cultures were placed on a heated microscope stage (Zeiss temperable insert P with objective heater) for 10 min at a constant 39&#x000B0;C before and during imaging. Imaging was performed using a Zeiss Pan-Neofluar 100_objective (1.3 N.A.), 2 &#x000D7; 2 camera binning, and minimal light exposure. For the quantification of mitochondria length, mitochondria labeled with MitoTracker green (Chicken sensory neurons) or Mitoview 633 (rat hippocampal neurons), were imaged at 30 min intervals over a 180 min timeframe. For mitochondrial fission and attempted fission rate quantification, neurons were co-transfected with pDsRed2-Mito and either pEYFP-C1-Drp1 or pEYFP-C1-Drp1K38A [previously generated in our lab (Armijo-Weingart et al., <xref ref-type="bibr" rid="B2">2019</xref>)]. Neurons were then imaged for 250 frames with a 3 s interframe interval. For analysis of changes in cytosolic and mitochondrial calcium, neurons were transfected with either GCaMP6 or mitoGCaMP2. Neurons were then imaged for 16 frames with a 1 min interframe interval.</p>
</sec>
<sec id="s2-12">
<title>Determination of Mitochondria Length</title>
<p>Imaging was performed as described in the tissue imaging and live imaging sections above. The length of mitochondria in the axon was measured using ImageJ software. Mitochondria length was determined by a line, segmented if the mitochondrion was not strictly linear, running from one end to the other of the mitochondrion. Occasionally, mitochondria in axons overlapped as clearly evidenced by the additive signal of their fluorescence in the region of overlap. Overlapping mitochondria were excluded from the analysis to ensure only mitochondria with clearly defined ends were used for quantification.</p>
</sec>
<sec id="s2-13">
<title>Determination of Rates of Fission and Fusion From Live Imaging Time-Lapse Videos</title>
<p>Instances of fission were determined manually by the user through frame-by-frame analysis. Using the settings described in the live imaging section each pixel in the resulting images has a radius of 0.12 &#x003BC;m. A completed fission event was defined as when the fluorescence intensity of the mitochondrion at the site of apparent fission had decreased to the background level of the axonal segment not containing mitochondria and the two resultant mitochondria were separated by over 5 pixels representing 0.6 &#x003BC;m. Attempted fission events were defined as mitochondria undergoing constrictions but not continuing into a full fission event, as the constriction sites returned to exhibit the prior width and intensity.</p>
</sec>
<sec id="s2-14">
<title>GCaMP6 and mitoGCaMP2 Analysis</title>
<p>All analyses were performed using Zeiss Axiovision software. For GCaMP6, regions of interest (ROIs) were drawn around the cut axon tip and 50 &#x003BC;m proximal to the cut. For mitoGCaMP2, ROIs were drawn around axonal mitochondria proximal to the cut site. Image acquisition was performed using excitation filters of 405 nm and 488 nm (Need specifications on Filters). Fluorescence time courses were computed as the mean pixel intensity of all the pixels within the ROI. At each timepoint, fluorescence intensity for both excitation filters (<italic>F</italic><sub>405</sub> and <italic>F</italic><sub>488</sub>) was calculated as mean fluorescence within the ROI, <italic>F</italic>, relative to the background <italic>F</italic><sub>0</sub> (<italic>F</italic> &#x02212; <italic>F</italic><sub>0</sub>). Data is reported as a ratio of <italic>F</italic><sub>488</sub>/<italic>F</italic><sub>405</sub>.</p>
</sec>
<sec id="s2-15">
<title>Statistical Analysis</title>
<p>All data were analyzed using Instat software (GraphPad Software Inc.). The software determines the normalcy of data sets using the Kolmogorov-Smirnov test. All data sets were determined to be non-normally distributed, therefore non-parametric analysis was used (Mann-Whitney test). For multiple comparison tests within experimental designs, non-parametric Dunn&#x02019;s <italic>post hoc</italic> tests were used. For data sets representing categorical data falling into bins the Fischer&#x02019;s exact test was used on the raw data, although the data are expressed as percentages for ease of appreciation. One or two tailed <italic>p</italic> values are reported based on whether the hypothesis did or did not dictate the directionality of the expected change in mean or median, respectively. All graphs were generated using Prism (GraphPad Software Inc.). Sample sizes and qualitative statistical presentation are denoted in figure legends or figures.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Spinal Cord Injury Decreases the Length of Axonal Mitochondria</title>
<p>To assess axonal mitochondrial morphology following spinal cord injury, the mitochondria of CST neurons of adult Sprague&#x02013;Dawley rats were labeled with mitochondrially targeted DsRed (mtDsRed) 4 weeks before performing dorsal column lesions at the C4-C5 level. Labeling was achieved by injecting adeno-associated virus co-expressing GFP and mitoDsRed (mitoDsRed/GFP/AAV) in the forelimb and hindlimb somatomotor cortex (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>). The mitochondria in non-injured axons at the C4-C5 level had a median length of 3.15 &#x003BC;m (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Mitochondria in C4-C5 CST axons severed following dorsal column lesion were analyzed in 100 &#x003BC;m bins from the site of injury as a function of time following injury. At 2 h following injury, mitochondria closest to the site of injury exhibited decreased length, while mitochondria more proximal along the injured axon maintained longer lengths although still decreased relative to controls (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Very small mitochondria in the vicinity of the injury site persisted for up to 3 days following injury (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Recovery of median mitochondrial length began by 1 week after injury with normal lengths almost fully restored by 2 weeks (<xref ref-type="fig" rid="F1">Figure 1C</xref>; see <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref> for data point distributions of the medians presented in <xref ref-type="fig" rid="F1">Figure 1C</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Fragmentation of axonal mitochondria following injury. <bold>(A)</bold> Examples of layer V neurons expressing mtDsRed and GFP. <bold>(B)</bold> Examples of mtDsRed labeled mitochondria in CST axons at C4&#x02013;5 in the uninjured control and at 2 h post-injury. <bold>(C)</bold> Graph of the median mitochondrial length as a function of time post-injury and distance from injury (Dunn multiple comparison tests). <italic>n</italic> = 3 rats per group. *<italic>p</italic> &#x0003C; 0.05, **<italic>p</italic> &#x0003C; 0.01. <bold>(D)</bold> Graph of the percentage of mitochondria in the &#x0003C;0.5 and 0.5&#x02013;1. 0 &#x003BC;m bins as a function of time at 0&#x02013;100 &#x003BC;m from the injury site. <bold>(E)</bold> Graph of the median mitochondrial lengths in retraction bulbs and axons (Mann-Whitney test). <bold>(F)</bold> Example of fragmented mitochondria in bulbs at 2 weeks after injury.</p></caption>
<graphic xlink:href="fnmol-14-668670-g0001.tif"/>
</fig>
<p>Mitochondria in the &#x0003C;0.5 &#x003BC;m range are considered dysfunctional (Reddy, <xref ref-type="bibr" rid="B67">2014</xref>; Galluzzi et al., <xref ref-type="bibr" rid="B28">2016</xref>; Hu et al., <xref ref-type="bibr" rid="B35">2017</xref>). In uninjured axons, less than 0.5% of mitochondria were shorter than 0.5 &#x003BC;m and only 4.4% of mitochondria fell within the 0.5&#x02013;1.0 &#x003BC;m range. Herein, mitochondria with length &#x0003C;0.5 &#x003BC;m are defined as fragments, while mitochondria 0.5&#x02013;1.0 &#x003BC;m are considered to be in the low normal range for length. By 2 h following injury, the percentage of mitochondria in the submicron range dramatically increased resulting in 53% of mitochondria displaying lengths &#x0003C;0.5 &#x003BC;m and 32% with length between 0.5 and 1.0 &#x003BC;m (<xref ref-type="fig" rid="F1">Figure 1D</xref>). The presence of increased mitochondrial fragments persisted until 3 days following injury before returning to non-injury control levels by 1-week post-injury (<xref ref-type="fig" rid="F1">Figure 1D</xref>). Fragmented mitochondria were identified throughout the distal region of severed axons and the axon tips. However, the length of mitochondria within retraction bulbs, defined as the distal end of the axon exhibiting a bulbous rounded morphology, relative to those in non-retraction bulb segments of axons, continued to exhibit sub-&#x003BC;m fragmentation up to at least 2 weeks (<xref ref-type="fig" rid="F1">Figures 1E,F</xref>).</p>
</sec>
<sec id="s3-2">
<title>Fragmentation of Axonal Mitochondria Is Associated With Increased Colocalization of Mitochondria With Mitophagy Markers Following Spinal Cord Injury</title>
<p>Fragmented dysfunctional mitochondria are removed through mitophagy1 (Ashrafi and Schwarz, <xref ref-type="bibr" rid="B4">2013</xref>). To determine if the mitochondrial fragmentation along CST axons observed after spinal cord injury correlates with increased mitophagy, we examined the association of mitochondria with the autophagocytic marker LC3 (Maday, <xref ref-type="bibr" rid="B52">2016</xref>; Maday and Holzbaur, <xref ref-type="bibr" rid="B53">2016</xref>). Adult Sprague-Dawley rats were injected with AAV co-expressing GFP-LC3 and mitoDsRed into the somatomotor cortex as described above. Four weeks after injections, the rats received a dorsal column lesion at the C4-C5 level to sever labeled CST axons. Line scans of fluorescent intensities from randomly selected axons were analyzed to measure the degree of LC3 association with mitochondria. Within the C4-C5 level of non-injured rats, GFP-LC3 florescence (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>, green line) was mostly uniformly distributed with few regions showing increased pixel intensity associated with DsRed labeled mitochondria (<xref ref-type="fig" rid="F2">Figure 2A</xref>, red line). Prior to the injury, we observed that only 7.1% of axonal mitochondria were associated with localized increases in LC3. At 2 h after injury, 18.5% of mitochondria were associated with localized increases in the levels of LC3 (<xref ref-type="fig" rid="F2">Figures 2C,F</xref>; hereafter referred to as LC3+ mitochondria). The increase in LC3+ mitochondria reached its peak 1 day after injury (31.8% LC3+ mitochondria) but continued until 3 days after injury (22.5% LC3+ mitochondria) before returning to non-injury control levels 7 days after injury (10.1% LC3+ mitochondria; <xref ref-type="fig" rid="F2">Figure 2D</xref>). The percentage of LC3+ mitochondria was not dependent on the distance from the injury site, as the percentage of LC3+ mitochondria was the same at all distances from the injury site at each time point (<xref ref-type="fig" rid="F2">Figure 2E</xref>). These observations indicate that there is an increase in mitophagy that correlates with mitochondrial fragmentation up to 3 days following spinal cord injury. To determine if the association of GFP-LC3 accumulation along axon with mitochondria might be due to volumetric or non-specific changes, we considered the association of GFP accumulation with mitochondria. For this analysis we focused on 1 day after the injury as at this time point reflects the peak value of the percentage of LC3+ mitochondria (<xref ref-type="fig" rid="F2">Figure 2D</xref>). Using the same criteria and analysis as for GFP-LC3, at 1 day after injury 8.1% of mitochondria (<italic>n</italic> = 20 axons, 148 mitochondria) were found associated with accumulation of GFP. These data indicate that the accumulation of GFP-LC3 noted in the injury conditions is not non-specific.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Injury-induced accumulation of LC3 at sites populated by mitochondria. <bold>(A)</bold> Example of LC3 distribution in uninjured axons relative to mitochondria. Line scan shows no increase in LC3 at the mitochondrion. For both traces, values are normalized to the mean intensity in regions not containing mitochondria. <bold>(B)</bold> As in <bold>(A)</bold> but showing three uninjured small mitochondria not showing LC3 accumulation. <bold>(C)</bold> Two hours after injury, LC3 is observed associated with mitochondria. Positive LC3 accumulation was defined as a maximal increase greater than 15% from the mean baseline in the axon segment defined by the mitochondrion. <bold>(D)</bold> Percentage of LC3+ mitochondria as a function of time post-injury. n = axons shown in bars. <bold>(E)</bold> Graph of percentage of LC3+ mitochondria as a function of distance from the site of injury. <bold>(F)</bold> Analysis of colocalization of GFP intensity with mitochondria positioning along axons. Using the same criteria as for GFP-LC3, at 1 day after injury reflective of when the percentage of GFP-LC3+ mitochondria peaks, only 8.1% of mitochondria are GFP+ (one case denoted by blue line). <italic>n</italic> = 3 rats per group.</p></caption>
<graphic xlink:href="fnmol-14-668670-g0002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Inhibition of Drp1-Mediated Fission Prevents Injury-Induced Fragmentation of Axonal Mitochondria</title>
<p>We next sought to assess the role of Drp1 mediated fission in the injury-induced mitochondrial shortening observed <italic>in vivo</italic>. mDivi-1 is a cell and blood-brain barrier permeable pharmacological inhibitor of Drp1 that blocks mitochondrial fission both <italic>in vitro</italic> and <italic>in vivo</italic> (Lackner and Nunnari, <xref ref-type="bibr" rid="B48">2010</xref>; Li et al., <xref ref-type="bibr" rid="B50">2016</xref>; Smith and Gallo, <xref ref-type="bibr" rid="B76">2017</xref>). Adult Sprague-Dawley rats were injected with mitoDsRed/AAV in the somatomotor cortex 4 weeks prior to CST severing at the C4-C5 level. mDivi-1 or vehicle was delivered <italic>via</italic> IP injections at 12 h before injury, and again immediately post-injury for the 1 day survival group, similar to published <italic>in vivo</italic> protocols (He et al., <xref ref-type="bibr" rid="B32">2016</xref>). Mitochondria were then analyzed at 2 h and 1-day post-injury in the distal 0&#x02013;300 &#x003BC;m of axons. mDivi-1 treatment decreased injury-induced mitochondrial fragmentation at 2 h and 1 day after injury. At 2 h, mDivi-1 treatment resulted in mitochondria with intermediate lengths, ranging between the non-injury and injury conditions (<xref ref-type="fig" rid="F3">Figure 3A</xref>). However, the 1-day treatment group exhibited mitochondrial lengths not significantly different than non-injured controls (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Analysis of the percentage of mitochondria in the fragmented range (&#x0003C;0.5 &#x003BC;m) and lower end of the normal range (0.5&#x02013;1 &#x003BC;m) revealed that mDivi-1 treatment prevented fragmentation at both 2 h and 1 day (<xref ref-type="fig" rid="F3">Figure 3B</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>mDivi1 blocks mitochondrial fragmentation and reduces the number of retraction bulbs. <bold>(A)</bold> Graph of median mitochondrial lengths with and without mDivi-1 treatment (Dunn Multiple Comparison test) <italic>n</italic> = 3 rats per group Statistical testing done in comparison to time-matched vehicle controls. <bold>(B)</bold> Percentage of mitochondria in the &#x0003C;0.5 (fragmented) and 0.5&#x02013;1 &#x003BC;m ranges with and without mDivi-1 treatment. <bold>(C)</bold> Examples of CST axons containing mitoDsRed labeled mitochondria adjacent to the injury site. In inset: note that the control exhibits numerous bright spherical retraction bulbs further from the lesion site and adjacent to the cavity. However, with mDivi-1 treatment, no cavities formed, axon did not appear to retract from lesion site, and the number of retraction bulbs greatly decreased. <bold>(D)</bold> Mean % of axons with retraction bulbs. <italic>n</italic> = 9 rats for each group. The data were analyzed using a Fisher&#x02019;s test on the raw aggregated categorical data within the group.</p></caption>
<graphic xlink:href="fnmol-14-668670-g0003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>The Drp-1 Fission Inhibitor mDivi-1 Reduces the Number of Retraction Bulbs on CST Axons</title>
<p>The fragmentation of axonal mitochondria was rapid and persistent in retraction bulbs even at longer times after injury. In order to determine whether mitochondria fragmentation could be a component of the mechanism that generates or supports retraction bulbs, the effects of mDivi-1 treatment on bulbs at the end of injured axons was examined. Adult Sprague-Dawley rats were injected with mtDsRed/GFP/AAV into the somatomotor cortex 4 weeks prior to the severing of CST axons at the C4-C5 level. The rats received IP injections of either mDivi-1 or vehicle the day before injury and once per day for 7 days after injury. Six weeks following injury, the animals were euthanized, and the spinal cord segments were analyzed. Vehicle injected controls showed cavitation at the injury site, axonal retraction, and numerous retraction bulbs at the distal tips of injured CST axons (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Consistent with a prior report (Li et al., <xref ref-type="bibr" rid="B50">2016</xref>), animals treated with mDivi-1 showed a decreased lesion volume with lesioned axons adjacent the lesion site. In addition, there was a 73% decrease in the number of retraction bulbs observed at axon tips (<xref ref-type="fig" rid="F3">Figure 3D</xref>).</p>
</sec>
<sec id="s3-5">
<title>Development of <italic>In vitro</italic> Model Systems to Study the Fission Response of Mitochondria to Axonal Injury</title>
<p>In order to perform mechanistic studies not amenable to <italic>in vivo</italic> examination and to determine whether the response of axonal mitochondria to axon severing may be cell-intrinsic within the cut end of axons, we sought to set up <italic>in vitro</italic> model systems for examining mitochondrial response to axonal injury. We investigated mitochondrial morphology after <italic>in vitro</italic> axonal injury using neurons from two species and representing early embryonic, late embryonic, and adult stages: (1) Embryonic day (E)7 and E14 chicken DRG explants, reflective of developmental stages when sensory axons are undergoing extension and have reached their proximal targets respectively (<xref ref-type="fig" rid="F4">Figures 4A&#x02013;D</xref>). (2) E18 rat dissociated hippocampal neurons (<xref ref-type="fig" rid="F4">Figure 4E</xref>) and (3) adult rat DRG dissociated neurons (<xref ref-type="fig" rid="F4">Figure 4F</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Axonal injury results in mitochondrial shortening <italic>in vitro</italic>. <bold>(A)</bold> Example of mitochondria stained with MitoTracker green in E14 chicken dorsal root ganglia (DRG) axons prior to axotomy. <bold>(B)</bold> Example of mitochondria in E14 chicken DRG axons 30 min following axotomy. <bold>(C)</bold> Median mitochondrial length in embryonic day 7 (E7) chicken DRG axons at 30 min intervals following axotomy. Dots represent individual mitochondria. <italic>n</italic> = 15 axons. <bold>(D)</bold> Median mitochondrial length in E14 chicken DRG axons at 30 min intervals following axotomy. <italic>n</italic> = 15 axons. <bold>(E)</bold> Median mitochondrial length in E18 rat hippocampal axons at 30 min intervals following axotomy. <italic>n</italic> = 10 axons. <bold>(F)</bold> Median mitochondrial length in adult rat DRG axons at 60 min intervals following axotomy <italic>n</italic> &#x02265; 9 axons per group. All statistical analyses done with Dunn&#x02019;s multiple comparison tests.</p></caption>
<graphic xlink:href="fnmol-14-668670-g0004.tif"/>
</fig>
<p>Mitochondria within embryonic chicken sensory axons were labeled with MitoTracker Green dye and axons were severed using a scalpel blade after 48 h in culture when axons attained lengths between 1&#x02013;1.5 mm. The mitochondrial length was monitored using live imaging. Prior to scalpel axotomy, axonal mitochondria showed median lengths of 1.63 &#x003BC;m and 2.41 &#x003BC;m in E7 and E14 neurons, respectively (<xref ref-type="fig" rid="F4">Figures 4A&#x02013;D</xref>), consistent with the prior demonstration of increased length in E14 neurons relative to E7 neurons (Armijo-Weingart et al., <xref ref-type="bibr" rid="B2">2019</xref>). Following axotomy, both E7 and E14 axons showed a significant reduction in mitochondrial length 30 min after injury. Mitochondrial length began to recover between 120 min and 150 min post-injury before returning to pre-injury levels 180 min following injury (<xref ref-type="fig" rid="F4">Figures 4C,D</xref>). The recovery from injury was faster in E7 (120 min) than E14 axons (180 min). E18 hippocampal neurons were cultured for 3 days, the time point at which axons attained lengths between 300 and 400 &#x003BC;m (stage III of <italic>in vitro</italic> development). Axonal mitochondria were labeled with Mitoview 633. Mitochondrial length decreased 30 min after injury and did not recover fully until at least 180 min (<xref ref-type="fig" rid="F4">Figure 4E</xref>). Similar analysis using adult rat DRG neurons with mitochondria labeled using MitoTracker Green showed that lengths were decreased one hour after injury and the decrease in length persisted until sometime after 180 min (<xref ref-type="fig" rid="F4">Figure 4F</xref>).</p>
<p>We next tested whether injury-induced mitochondrial shortening in sensory axons is Drp1 dependent <italic>in vitro</italic>. E14 chicken DRG explants were incubated with either DMSO (control) or 20 &#x003BC;M mDivi-1 for 30 min prior to scalpel blade axotomy. Mitochondria within sensory axons were labeled with MitoTracker green. Following axotomy mitochondrial size was monitored for 180 min. As with untreated neurons (<xref ref-type="fig" rid="F4">Figure 4D</xref>), DMSO treated neurons demonstrated prominent mitochondrial shortening 30 min after injury before gradually returning to pre-injury lengths by 180 min. Neurons treated with mDivi-1 did not show mitochondrial shortening at any time point following axotomy (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>). Additionally, we tested whether injury-induced mitochondrial shortening in hippocampal neurons is Drp1 dependent <italic>in vitro</italic>. Axonal mitochondria length was measured in E18 hippocampal neurons (as in <xref ref-type="fig" rid="F4">Figure 4E</xref>) treated with either DMSO or 20 &#x003BC;M mDivi-1 30 min before severing using a micro-needle as previously described (Gallo, <xref ref-type="bibr" rid="B26">2004</xref>). The mitochondrial length was monitored using live imaging. Prior to axotomy, DMSO treated neurons displayed axonal mitochondria with a median length of 1.86 &#x003BC;m. The median mitochondrial length was significantly reduced at 30 min after axotomy. By 180 min following injury, median mitochondrial length was still significantly smaller than before axotomy but was trending toward recovery of pre-axotomy length (<xref ref-type="fig" rid="F5">Figures 5C,D</xref>). Neurons treated with 20 &#x003BC;M mDivi-1 showed no change in median mitochondrial length over the 180-min monitoring period (<xref ref-type="fig" rid="F5">Figure 5C</xref>). These observations indicate that injury-induced mitochondrial shortening <italic>in vitro</italic> is a Drp1 dependent process.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Injury-induced mitochondrial fission is Drp1 dependent <italic>in vitro</italic>. <bold>(A)</bold> Median mitochondrial length in E14 chicken DRG axons with or without mDivi-1. Dots represent individual mitochondria (Dunn&#x02019;s multiple comparison tests). <italic>n</italic> = 15 axons for each group. <bold>(B)</bold> Examples of MitoTracker green stained mitochondria in E14 chicken DRG axons. <bold>(C)</bold> Median mitochondrial length in E18 rat hippocampal axons with or without mDivi-1. Dots represent individual mitochondria (Dunn&#x02019;s multiple comparison tests). <italic>n</italic> = 10 axons for each group. <bold>(D)</bold> Examples of Mitoview633 stained mitochondria in E18 rat hippocampal axons. <bold>(E)</bold> Example of mitochondria labeled with mitoDsRed undergoing fission or attempted fission following axonal injury. At 18 s a constriction is apparent at the site denoted by the arrow but by 24 s the constriction is no longer detectable, and the mitochondrion has returned to its prior morphology. <bold>(F)</bold> Graph of fission events per 10 &#x003BC;m of mitochondrial length per minute in E14 chicken DRG axons transfected with either YFP-Drp1 or YFP-Drp1K38A (DNDrp1) following injury (Dunn&#x02019;s multiple comparison tests). <italic>n</italic> = 15 axons. <bold>(G)</bold> Graph of attempted fission events per 10 &#x003BC;m of mitochondrial length per minute in E14 chicken DRG axons transfected with either YFP-Drp1 or YFP-Drp1K38A (DNDrp1) following injury (Dunn&#x02019;s multiple comparison tests). <italic>n</italic> = 15 axons.</p></caption>
<graphic xlink:href="fnmol-14-668670-g0005.tif"/>
</fig>
<p>To further test the hypothesis that mitochondria shortening is due to Drp1 mediated fission, we expressed a dominant-negative Drp1 mutant (Drp1K38A) that lacks GTPase activity and is, therefore, unable to carry out mitochondrial fission (Pitts et al., <xref ref-type="bibr" rid="B65">1999</xref>; Barsoum et al., <xref ref-type="bibr" rid="B7">2006</xref>). E14 chicken DRGs were transfected with either YFP-Drp1 (control) and mitoDsRed or YFP-Drp1K38A and mitoDsRed. Single axon axotomy was performed using a micro-needle as done previously (Gallo, <xref ref-type="bibr" rid="B26">2004</xref>). Because transfection with Drp1K38A allows for unopposed mitochondrial fusion, mitochondria become elongated (20&#x02013;30 &#x003BC;m or larger) in sensory neurons by 24 h of expression (Armijo-Weingart et al., <xref ref-type="bibr" rid="B2">2019</xref>). Thus, comparison of mitochondrial length after axotomy between control and Drp1K38A expressing neurons is not a reasonable analysis. We, therefore, measured the number of fission events and attempted fission events per 10 microns of mitochondria per min for each group monitored over a 15-min period. As previously described (Armijo-Weingart et al., <xref ref-type="bibr" rid="B2">2019</xref>), a fission event was defined as when the fluorescence intensity of the mitochondrion at the site of apparent fission had decreased to the background level of the axonal segment not containing mitochondria and the two resultant mitochondria were separated by over 5 pixels representing 0.6 &#x003BC;m (<xref ref-type="fig" rid="F5">Figure 5E</xref>). Attempted fission events were defined as mitochondria that underwent apparent constrictions but did not continue into a full fission event, as the constriction sites returned to exhibit the prior width and intensity (<xref ref-type="fig" rid="F5">Figure 5E</xref>). It should also be noted that overexpression of WT Drp1 does not increase mitochondrial fission events at baseline (Armijo-Weingart et al., <xref ref-type="bibr" rid="B2">2019</xref>). Axotomy resulted in increased fission and attempted fission events in control YFP-Drp1 expressing neurons (<xref ref-type="fig" rid="F5">Figures 5F,G</xref>). The increases in fission and attempted fission events in response to axotomy were abolished by expression of YFP-Drp1K38A (<xref ref-type="fig" rid="F5">Figures 5F,G</xref>).</p>
</sec>
<sec id="s3-6">
<title>Injury-Induced Mitochondrial Fission Requires the Mitochondrial Calcium Uniporter</title>
<p>Following axotomy, there is an influx of calcium into the axon, which is important in the formation of either a retraction bulb or a new growth cone (Bradke et al., <xref ref-type="bibr" rid="B10">2012</xref>). We first transfected E7 chicken DRG neurons with GCaMP6, a cytosolic, ratiometric calcium-sensing protein (Chen et al., <xref ref-type="bibr" rid="B15">2013</xref>). Individual axons were severed using a micro-needle, as above, and calcium changes were monitored over a 15-min period with live imaging. As expected axotomy caused a sustained influx of calcium resulting in a two-fold increase in GCaMP6 fluorescence (<xref ref-type="fig" rid="F6">Figures 6A,B</xref>). To determine whether intra-mitochondrial calcium levels are increased following axotomy, E7 chicken DRG neurons were transfected with a mitochondrially tagged calcium-sensing protein, mitoGCaMP2. We monitored mitochondrial calcium levels for 15 min following axotomy, observing a steady increase in mitochondrial calcium culminating in a three-fold increase in mitoGCaMP2 fluorescence at 15 min post axotomy (<xref ref-type="fig" rid="F6">Figures 6C,D</xref>). To determine if this increase in mitochondrial calcium was dependent on injury-induced fission, we pretreated neurons with either DMSO or 20 &#x003BC;M mDivi-1 as above. Blocking fission following axotomy had no effect on mitochondrial calcium demonstrating that this was not a fission-dependent process (<xref ref-type="fig" rid="F6">Figure 6C</xref>). Given the increase in cytosolic calcium after axotomy, we next addressed if injury-induced mitochondrial fission may be dependent on an increase in mitochondrial calcium. Calcium is taken up into mitochondria through the mitochondrial calcium uniporter (MCU) present on the mitochondrial inner membrane (Gunter and Gunter, <xref ref-type="bibr" rid="B30">1994</xref>). RU360 is an established inhibitor of calcium fluxes through MCU (Matlib et al., <xref ref-type="bibr" rid="B54">1998</xref>; Zhou et al., <xref ref-type="bibr" rid="B89">1998</xref>; Vanderluit et al., <xref ref-type="bibr" rid="B82">2003</xref>). E7 chicken DRG explants were treated with either 10 &#x003BC;M RU360 or vehicle and mitochondria were labeled with MitoTracker Green 30 min prior to scalpel axotomy. Following axotomy, mitochondrial size was monitored for 30 min using live imaging. Application of RU360 had no effect on mitochondrial size in the absence of axotomy during the 30-min imaging period (<xref ref-type="fig" rid="F6">Figure 6E</xref>). At 30 min after axotomy, vehicle treated neurons displayed a significantly reduced median mitochondrial length when compared to mitochondrial length prior to axotomy, while neurons treated with 10 &#x003BC;M RU360 displayed no change in median mitochondrial length (<xref ref-type="fig" rid="F6">Figure 6E</xref>). These observations indicate that ion fluxes through MCU are a required component of the mechanism that drives injury-induced mitochondrial fission <italic>in vitro</italic>. In order to determine whether mitochondrial ion fluxes through MCU could also have a role in the <italic>in vivo</italic> response of axonal mitochondrial to spinal cord injury, adult Sprague-Dawley rats were injected with mtDsRed/GFP/AAV into the somatomotor cortex 4 weeks prior to the severing of CST axons at the C4-C5 level. Immediately following injury, gel foam soaked in either vehicle or 10 mM RU360 was placed at the site of injury. The animals were euthanized either 2 h or 24 h following injury and mitochondrial size as a function of time after injury and distance from the site of injury was analyzed as previously described. Treatment with RU360 resulted in longer mitochondria after injury compared to time-matched controls (<xref ref-type="fig" rid="F6">Figure 6F</xref>). However, in all cases, the length of mitochondria was also shorter from that of uninjured controls (<xref ref-type="fig" rid="F6">Figure 6F</xref>). Animals treated with RU360 showed greatly attenuated fragmentation in the vicinity of the injury site (0&#x02013;100 micron) at either 2 h or 24 h post-injury (red percentages and <italic>p</italic> values in <xref ref-type="fig" rid="F6">Figure 6F</xref>), indicating that mitochondrial ion fluxes through MCU are also a required component of the mechanism driving injury-induced mitochondrial fission <italic>in vivo</italic>.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Injury-induced mitochondrial fission requires mitochondrial calcium uptake both <italic>in vitro</italic> and <italic>in vivo</italic>. <bold>(A)</bold> Graph of cytosolic GCaMP6 fluorescence ratio (488 nm/405 nm) in E7 chicken DRG axons following axotomy (Dunn Multiple Comparison test). <italic>n</italic> = 10 axons per group. <bold>(B)</bold> Ratiometric false-colored images of the GCaMP6 signal in a representative axon pre and 5 min post axotomy. The black arrow denotes the location of the axotomy. As reflected by the ratiometric measurements by 5 min the GCaMP6 signal is elevated, particularly in axonal swellings that form after axotomy. <bold>(C)</bold> Graph of mitoGCaMP2 fluorescence ratio (488 nm/405 nm) in E7 chicken DRG axons following axotomy with or without mDivi-1 (Dunn Multiple Comparison test). <italic>n</italic> = 10 axons per group. <bold>(D)</bold> Ratiometric false-colored images of the mitoGCaMP2 signal in a representative axon pre and 5 min post axotomy. As in panel <bold>(B)</bold> the arrow denotes the location of axotomy. In this example, the field of view containing the axon was shifted leftward while the axotomy was occurring and is not visible in the preimages. As shown quantitatively in panel <bold>(C)</bold> the ratio in mitochondria is increased by 10 min post-injury. <bold>(E)</bold> Graph of median mitochondrial length in E7 chicken DRG axons with or without axotomy and with or without RU360 (Dunn Multiple Comparison test). <italic>n</italic> = 10 axons per group. <bold>(F)</bold> Graph of median mitochondrial length in adult rat CST axons following the injury at the C4-C5 level with or without RU360 (Dunn Multiple Comparison test). <italic>n</italic> = 3 rats per group. Statistical testing done in comparison to time-matched vehicle controls. All groups are different from the uninjured at <italic>p</italic> &#x0003C; 0.0001. The percentage of fragmented (&#x0003C;0.5 micron) mitochondria in the 0&#x02013;100 micron binds is shown in red. Fisher exact tests between time-matched control and 10 mM RU360 treatment groups are shown in red.</p></caption>
<graphic xlink:href="fnmol-14-668670-g0006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Dysfunctional mitochondria have consistently been associated with neuronal disease and injury (Reddy et al., <xref ref-type="bibr" rid="B68">2011</xref>; Galloway et al., <xref ref-type="bibr" rid="B27">2012</xref>; Reddy, <xref ref-type="bibr" rid="B67">2014</xref>; Luo et al., <xref ref-type="bibr" rid="B51">2015</xref>; Wu et al., <xref ref-type="bibr" rid="B86">2016</xref>, <xref ref-type="bibr" rid="B85">2017</xref>; Cherubini and Gines, <xref ref-type="bibr" rid="B16">2017</xref>). In this study, we used both <italic>in vitro</italic> and <italic>in vivo</italic> models to investigate the response of axonal mitochondria to axonal injury. Mitochondria within CST axons undergo rapid fragmentation following severing. Mitochondrial fragmentation was persistent within retraction bulbs even after mitochondria in more proximal regions of the axon had recovered to normal length. Injury-induced mitochondrial shortening was also found in three different <italic>in vitro</italic> models of axonal injury. Drp1-mediated fission of mitochondria into fragments smaller than 0.5 &#x003BC;m is associated with neuronal malfunction and cell death in a variety of neurotoxic and disease states (Karbowski, <xref ref-type="bibr" rid="B40">2010</xref>; Otera et al., <xref ref-type="bibr" rid="B60">2013</xref>; Kasahara and Scorrano, <xref ref-type="bibr" rid="B41">2014</xref>; Pradeep et al., <xref ref-type="bibr" rid="B66">2014</xref>; Reddy, <xref ref-type="bibr" rid="B67">2014</xref>; Balog et al., <xref ref-type="bibr" rid="B5">2016</xref>; Bertholet et al., <xref ref-type="bibr" rid="B8">2016</xref>; Galluzzi et al., <xref ref-type="bibr" rid="B28">2016</xref>; Hu et al., <xref ref-type="bibr" rid="B35">2017</xref>). The observed fragmentation of axonal mitochondria following injury could severely reduce mitochondrial bioenergetics and impair growth from the cut axon tip. This is in agreement with studies showing that, at the tissue level, mitochondrial respiration following spinal cord injury is impaired (Jin et al., <xref ref-type="bibr" rid="B38">2004</xref>; McEwen et al., <xref ref-type="bibr" rid="B55">2007</xref>; Sullivan et al., <xref ref-type="bibr" rid="B79">2007</xref>; Patel et al., <xref ref-type="bibr" rid="B63">2009</xref>, <xref ref-type="bibr" rid="B62">2010</xref>), and there is a rise in mitochondrial oxidative stress (Jin et al., <xref ref-type="bibr" rid="B38">2004</xref>; McEwen et al., <xref ref-type="bibr" rid="B55">2007</xref>; Sullivan et al., <xref ref-type="bibr" rid="B79">2007</xref>; Patel et al., <xref ref-type="bibr" rid="B63">2009</xref>).</p>
<p>These findings raise the question of the physiological purpose for injury-induced mitochondrial fission. The speed and distance of mitochondrial movement are inversely related to mitochondrial length (Steketee et al., <xref ref-type="bibr" rid="B78">2012</xref>; Narayanareddy et al., <xref ref-type="bibr" rid="B58">2014</xref>). Additionally, mitochondrial fission is necessary for axonal branching (Spillane et al., <xref ref-type="bibr" rid="B77">2013</xref>; Armijo-Weingart et al., <xref ref-type="bibr" rid="B2">2019</xref>). This raises the possibility that the fission of mitochondria into smaller, but not dysfunctional, fragments could increase their transport rate within axons to aid the redistribution of healthy mitochondria within axons, increasing the growth potential. However, it is unclear why many axonal mitochondria within the CNS become fragmented following injury, rendering them incapable of aiding in neuronal growth and recovery.</p>
<p>Retraction bulbs are formed as a consequence of new growth cone formation failure and the continued flow of axoplasm to the injured tip resulting in a swollen, bulbous axonal end. Retraction bulbs are marked by the presence of accumulated organelles, such as smooth endoplasmic reticulum and mitochondria, as well as disorganized microtubules (Hill, <xref ref-type="bibr" rid="B33">2017</xref>). The fragmentation of mitochondria following injury may contribute to the formation of retraction bulbs, a main contributor to the lack of regenerative potential in the CNS. We observed that fragmented mitochondria persist within retraction bulbs up to 2 weeks after injury (<xref ref-type="fig" rid="F1">Figure 1E</xref>), a time at which axonal mitochondria have re-attained lengths comparable to axonal mitochondria in non-injured controls. For axonal regrowth to occur after injury, the injured axon must first form a growth cone, an energy demanding multistep process that relies on ATP produced by healthy mitochondria (Campbell and Holt, <xref ref-type="bibr" rid="B12">2001</xref>; Verma et al., <xref ref-type="bibr" rid="B83">2005</xref>; Hill, <xref ref-type="bibr" rid="B33">2017</xref>). Multiple recent studies show that increasing delivery of healthy mitochondria into injured axon tips positively contributes to axonal regeneration (Cartoni et al., <xref ref-type="bibr" rid="B13">2016</xref>; Han et al., <xref ref-type="bibr" rid="B31">2016</xref>; Zhou et al., <xref ref-type="bibr" rid="B88">2016</xref>). Therefore, we posit that the injury-induced mitochondrial fragmentation in the CNS results in energy deficiency at the cut axon tip, leading to the formation of a retraction bulb and the failure of growth cone formation. Our observation that inhibiting injury-induced mitochondrial fragmentation using mDivi-1 reduced the number of retraction bulbs reinforces this hypothesis. Additionally, inhibiting injury-induced mitochondrial fragmentation reduced the lesion volume. It should be noted that the reduction in lesion volume and the reduction in the number of retraction bulbs may be caused by independent effects of mDivi-1 in different cell types. A previous study demonstrated that mDivi-1 treatment following spinal cord injury prevented astrocyte activation and astroglial scar formation, thereby reducing lesion volume (Li et al., <xref ref-type="bibr" rid="B50">2016</xref>). Nonetheless, our findings demonstrate that inhibition of injury-induced mitochondrial fragmentation prevents retraction bulb formation and may ultimately contribute to axonal regeneration following injury.</p>
<p>Dysfunctional mitochondria are detrimental due to their incapability to produce enough ATP to meet cellular demand and increased generation of reactive oxygen species (ROS). Dysfunctional mitochondria are removed through mitophagy. Following spinal cord injury, a sharp increase in mitophagy occurs, as measured by LC3-mitochondria colocalization, beginning at 2 h after injury and peaking at 1 day following injury, before returning to non-injury control levels 7 days after injury. This timeline coincides with the observation that mitochondria in the vicinity of the injury site are fragmented up to 3 days following injury before showing partial recovery of normal mitochondrial length. These observations are consistent with the notion that the injury-induced mitochondrial fragments are dysfunctional and must therefore be removed from the axon in the interest of maintaining neuronal health (Ribas and Lingor, <xref ref-type="bibr" rid="B69">2015</xref>; Ribas et al., <xref ref-type="bibr" rid="B70">2015</xref>). Activation of autophagy using a cell permeable Tat-Beclin1 peptide, a key component of autophagosome formation (Molino et al., <xref ref-type="bibr" rid="B57">2017</xref>), reduces retraction bulb formation acutely, as well as axonal dieback 6 weeks after SCI (He et al., <xref ref-type="bibr" rid="B32">2016</xref>). In contrast, inhibiting VPS34, a phosphoinositide-3-kinase (PI3K) involved in autophagosome initiation, using 3MA prevents acute axonal degeneration and neuronal degeneration after either optic nerve injury or SCI (Knoferle et al., <xref ref-type="bibr" rid="B43">2010</xref>; Bisicchia et al., <xref ref-type="bibr" rid="B9">2017</xref>). Although the underlying models are different and could differentially modulate the rate at which autophagosomes are cleared, another explanation is that 3MA is a general PI3K inhibitor, and not specific to VPS34 (Knight and Shokat, <xref ref-type="bibr" rid="B42">2007</xref>; Kong and Yamori, <xref ref-type="bibr" rid="B44">2008</xref>). Our observations suggest that the specific promotion of mitophagy following spinal cord injury possibly proves beneficial in axonal regeneration and recovery.</p>
<p>Calcium dynamics following injury are important in determining whether a new growth cone or a retraction bulb will form (Bradke et al., <xref ref-type="bibr" rid="B10">2012</xref>), thus we investigated whether calcium may contribute to Drp1-dependent injury-induced mitochondrial fragmentation. Following injury, there was an increase in both cytosolic and mitochondrial calcium content. Increases in mitochondrial calcium are due to increased permeability of the MCU to divalent ions, largely calcium and zinc. The increase in mitochondrial calcium content was not blocked by the application of mDivi-1, indicating that the observed mitochondrial uptake is independent of injury-induced mitochondrial fission. Inhibiting ionic fluxes through the MCU using RU360, both <italic>in vitro</italic> and <italic>in vivo</italic>, blocked injury-induced mitochondrial fission, showing that mitochondrial ionic uptake is a component of the mechanism underlying injury-induced mitochondrial fragmentation. Mitochondria are composed of an outer mitochondrial membrane (OMM) and an inner mitochondrial membrane (IMM), both of which must be fully constricted for fission to occur (Kuroiwa et al., <xref ref-type="bibr" rid="B47">2008</xref>). Constriction of the IMM was shown to be dependent on mitochondrial calcium uptake, and could be blocked by administration of RU360 (Cho et al., <xref ref-type="bibr" rid="B17">2017</xref>). Thus, the influx of mitochondrial calcium following injury may be required for fission to come to completion due to its role in IMM constriction. Additionally, Drp1 alone is unable to initiate mitochondrial constriction because Drp1 oligomers can only form contractile rings with a diameter of up to 100 nm, while mitochondria have diameters between 0.5 and 1.0 &#x003BC;m (Ingerman et al., <xref ref-type="bibr" rid="B36">2005</xref>; Mears et al., <xref ref-type="bibr" rid="B56">2011</xref>). Therefore, mitochondrial fission requires a pre-constriction step, in which actin filaments promote direct contact of mitochondria with the endoplasmic reticulum (ER; Friedman et al., <xref ref-type="bibr" rid="B25">2011</xref>; Korobova et al., <xref ref-type="bibr" rid="B45">2013</xref>). A rise in cytosolic calcium promotes actin-dependent pre-constriction, bringing mitochondria into closer contact with ER, allowing for efficient uptake of calcium into mitochondria through the MCU (Chakrabarti et al., <xref ref-type="bibr" rid="B14">2018</xref>). These results suggest that following injury, a large influx of calcium into the cytosol results in actin polymerization, which drives mitochondrial pre-constriction and mitochondrial-ER contact. This in turn leads to an uptake of calcium into the mitochondria through the MCU and promotes constriction of the IMM priming mitochondria for Drp1-dependent fission. We cannot rule out a possible role for ionic fluxes through the MCU in regulating aspects of the Drp1-dependent mechanism of fission following injury, but given that the latter is occurring on the outer mitochondrial membrane while the fluxes are inside the mitochondrion this seems unlikely. While a case can be made for the role of mitochondrial calcium uptake, zinc uptake may also contribute. During fission, Drp1 promotes the flux of zinc through the MCU that in turn serves to suppress mitochondrial membrane potential and target mitochondria for mitophagy (Cho et al., <xref ref-type="bibr" rid="B19">2019</xref>). Thus, both calcium and zinc fluxes through the MCU could contribute to injury-induced mitochondria fragmentation and mitophagy. Regardless of the specific ion responsible, the mechanistic insight that fluxes through MCU is required may provide yet another target for inhibiting injury-induced mitochondrial fragmentation and perhaps promoting axonal regeneration in the future.</p>
<p>This report details the novel findings that following injury, axonal mitochondria of CST neurons undergo rapid fragmentation in a Drp1-dependent process. Mitochondrial fragments persist in retraction bulbs and may play a role in their initial formation or maintenance. An axonal injury also results in an increase in mitophagy, indicating that the injury-induced mitochondrial fragments are dysfunctional. Finally, we show that mitochondrial calcium uptake is a mechanistic contributor to injury-induced mitochondrial fragmentation. These observations pave the way for new strategies aimed at axonal mitochondrial dynamics in the effort to prevent axonal dieback, and to promote axonal regeneration following injury.</p>
</sec>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal studies were reviewed and approved by Institutional Animal Care and Use Committee.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>JK, SL, and AP performed the majority of experimental studies. JK, GG, and GS designed the majority of experiments, performed data analyses, wrote and edited the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We would also like to thank Dr. Yingpeng Liu and Fengsong Qin for viral production.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by NINDS NS095471 to GG, Shriners Hospitals for Pediatric Research 85120-PHI-19 to GS and GG, and 84051-PHI-16 to GS.</p>
</fn>
</fn-group>
<sec id="s9">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fnmol.2021.668670/full&#x00023;supplementary-material">https://www.frontiersin.org/articles/10.3389/fnmol.2021.668670/full&#x00023;supplementary-material</ext-link>.</p>
<supplementary-material xlink:href="Image_1.JPEG" id="SM1" mimetype="application/JPEG" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY FIGURE 1</label>
<caption><p>Distribution of mitochondrial length measurements for the post-injury time course and distance from injury suite analysis. Each dot represents a mitochondrion.</p></caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abeti</surname> <given-names>R.</given-names></name> <name><surname>Abramov</surname> <given-names>A. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondrial Ca(2+) in neurodegenerative disorders</article-title>. <source>Pharmacol. Res.</source> <volume>99</volume>, <fpage>377</fpage>&#x02013;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2015.05.007</pub-id><pub-id pub-id-type="pmid">26013908</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armijo-Weingart</surname> <given-names>L.</given-names></name> <name><surname>Ketschek</surname> <given-names>A.</given-names></name> <name><surname>Sainath</surname> <given-names>R.</given-names></name> <name><surname>Pacheco</surname> <given-names>A.</given-names></name> <name><surname>Smith</surname> <given-names>G. M.</given-names></name> <name><surname>Gallo</surname> <given-names>G.</given-names></name></person-group> (<year>2019</year>). <article-title>Neurotrophins induce fission of mitochondria along embryonic sensory axons</article-title>. <source>eLife</source> <volume>8</volume>:<fpage>e49494</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.49494</pub-id><pub-id pub-id-type="pmid">31789589</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arun</surname> <given-names>S.</given-names></name> <name><surname>Liu</surname> <given-names>L.</given-names></name> <name><surname>Donmez</surname> <given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitochondrial biology and neurological diseases</article-title>. <source>Curr. Neuropharmacol.</source> <volume>14</volume>, <fpage>143</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.2174/1570159x13666150703154541</pub-id><pub-id pub-id-type="pmid">26903445</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname> <given-names>G.</given-names></name> <name><surname>Schwarz</surname> <given-names>T. L.</given-names></name></person-group> (<year>2013</year>). <article-title>The pathways of mitophagy for quality control and clearance of mitochondria</article-title>. <source>Cell Death Differ.</source> <volume>20</volume>, <fpage>31</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2012.81</pub-id><pub-id pub-id-type="pmid">22743996</pub-id></citation></ref>
<ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayuso</surname> <given-names>E.</given-names></name> <name><surname>Mingozzi</surname> <given-names>F.</given-names></name> <name><surname>Montane</surname> <given-names>J.</given-names></name> <name><surname>Leon</surname> <given-names>X.</given-names></name> <name><surname>Anguela</surname> <given-names>X. M.</given-names></name> <name><surname>Haurigot</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency</article-title>. <source>Gene Ther.</source> <volume>17</volume>, <fpage>503</fpage>&#x02013;<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1038/gt.2009.157</pub-id><pub-id pub-id-type="pmid">19956269</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balog</surname> <given-names>J.</given-names></name> <name><surname>Mehta</surname> <given-names>S. L.</given-names></name> <name><surname>Vemuganti</surname> <given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitochondrial fission and fusion in secondary brain damage after CNS insults</article-title>. <source>J. Cereb. Blood Flow Metab.</source> <volume>36</volume>, <fpage>2022</fpage>&#x02013;<lpage>2033</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X16671528</pub-id><pub-id pub-id-type="pmid">27677674</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnhart</surname> <given-names>E. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Mechanics of mitochondrial motility in neurons</article-title>. <source>Curr. Opin. Cell Biol.</source> <volume>38</volume>, <fpage>90</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceb.2016.02.022</pub-id><pub-id pub-id-type="pmid">26986984</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barsoum</surname> <given-names>M. J.</given-names></name> <name><surname>Yuan</surname> <given-names>H.</given-names></name> <name><surname>Gerencser</surname> <given-names>A. A.</given-names></name> <name><surname>Liot</surname> <given-names>G.</given-names></name> <name><surname>Kushnareva</surname> <given-names>Y.</given-names></name> <name><surname>Graber</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons</article-title>. <source>EMBO J.</source> <volume>25</volume>, <fpage>3900</fpage>&#x02013;<lpage>3911</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601253</pub-id><pub-id pub-id-type="pmid">16874299</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertholet</surname> <given-names>A. M.</given-names></name> <name><surname>Delerue</surname> <given-names>T.</given-names></name> <name><surname>Millet</surname> <given-names>A. M.</given-names></name> <name><surname>Moulis</surname> <given-names>M. F.</given-names></name> <name><surname>David</surname> <given-names>C.</given-names></name> <name><surname>Daloyau</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Mitochondrial fusion/fission dynamics in neurodegeneration and neuronal plasticity</article-title>. <source>Neurobiol. Dis.</source> <volume>90</volume>, <fpage>3</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2015.10.011</pub-id><pub-id pub-id-type="pmid">26494254</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bisicchia</surname> <given-names>E.</given-names></name> <name><surname>Latini</surname> <given-names>L.</given-names></name> <name><surname>Cavallucci</surname> <given-names>V.</given-names></name> <name><surname>Sasso</surname> <given-names>V.</given-names></name> <name><surname>Nicolin</surname> <given-names>V.</given-names></name> <name><surname>Molinari</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Autophagy inhibition favors survival of rubrospinal neurons after spinal cord hemisection</article-title>. <source>Mol. Neurobiol.</source> <volume>54</volume>, <fpage>4896</fpage>&#x02013;<lpage>4907</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-0031-z</pub-id><pub-id pub-id-type="pmid">27514755</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bradke</surname> <given-names>F.</given-names></name> <name><surname>Fawcett</surname> <given-names>J. W.</given-names></name> <name><surname>Spira</surname> <given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Assembly of a new growth cone after axotomy, the precursor to axon regeneration</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>13</volume>, <fpage>183</fpage>&#x02013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3176</pub-id><pub-id pub-id-type="pmid">22334213</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brennan-Minnella</surname> <given-names>A. M.</given-names></name> <name><surname>Arron</surname> <given-names>S. T.</given-names></name> <name><surname>Chou</surname> <given-names>K. M.</given-names></name> <name><surname>Cunningham</surname> <given-names>E.</given-names></name> <name><surname>Cleaver</surname> <given-names>J. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Sources and consequences of oxidative damage from mitochondria and neurotransmitter signaling</article-title>. <source>Environ. Mol. Mutagen.</source> <volume>57</volume>, <fpage>322</fpage>&#x02013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1002/em.21995</pub-id><pub-id pub-id-type="pmid">27311994</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname> <given-names>D. S.</given-names></name> <name><surname>Holt</surname> <given-names>C. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation</article-title>. <source>Neuron</source> <volume>32</volume>, <fpage>1013</fpage>&#x02013;<lpage>1026</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(01)00551-7</pub-id><pub-id pub-id-type="pmid">11754834</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cartoni</surname> <given-names>R.</given-names></name> <name><surname>Norsworthy</surname> <given-names>M. W.</given-names></name> <name><surname>Bei</surname> <given-names>F.</given-names></name> <name><surname>Wang</surname> <given-names>C.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>The Mammalian-specific protein armcx1 regulates mitochondrial transport during axon regeneration</article-title>. <source>Neuron</source> <volume>92</volume>, <fpage>1294</fpage>&#x02013;<lpage>1307</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.10.060</pub-id><pub-id pub-id-type="pmid">28009275</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname> <given-names>R.</given-names></name> <name><surname>Ji</surname> <given-names>W. K.</given-names></name> <name><surname>Stan</surname> <given-names>R. V.</given-names></name></person-group> (<year>2018</year>). <article-title>INF2-mediated actin polymerization at the ER stimulates mitochondrial calcium uptake, inner membrane constriction and division</article-title>. <source>J. Cell Biol.</source> <volume>217</volume>, <fpage>251</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201709111</pub-id><pub-id pub-id-type="pmid">29142021</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>T. W.</given-names></name> <name><surname>Wardill</surname> <given-names>T. J.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name> <name><surname>Pulver</surname> <given-names>S. R.</given-names></name> <name><surname>Renninger</surname> <given-names>S. L.</given-names></name> <name><surname>Baohan</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Ultrasensitive fluorescent proteins for imaging neuronal activity</article-title>. <source>Nature</source> <volume>499</volume>, <fpage>295</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1038/nature12354</pub-id><pub-id pub-id-type="pmid">23868258</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cherubini</surname> <given-names>M.</given-names></name> <name><surname>Gines</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Mitochondrial fragmentation in neuronal degeneration, Toward an understanding of HD striatal susceptibility</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>483</volume>, <fpage>1063</fpage>&#x02013;<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.08.042</pub-id><pub-id pub-id-type="pmid">27514446</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>B.</given-names></name> <name><surname>Cho</surname> <given-names>H. M.</given-names></name> <name><surname>Jo</surname> <given-names>Y.</given-names></name> <name><surname>Kim</surname> <given-names>H. D.</given-names></name> <name><surname>Song</surname> <given-names>M.</given-names></name> <name><surname>Moon</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Constriction of the mitochondrial inner compartment is a priming event for mitochondrial division</article-title>. <source>Nat. Commun.</source> <volume>8</volume>:<fpage>15754</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms15754</pub-id><pub-id pub-id-type="pmid">28598422</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>B.</given-names></name> <name><surname>Choi</surname> <given-names>S. Y.</given-names></name> <name><surname>Cho</surname> <given-names>H. M.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Sun</surname> <given-names>W.</given-names></name></person-group> (<year>2013</year>). <article-title>Physiological and pathological significance of dynamin-related protein 1 (drp1)-dependent mitochondrial fission in the nervous system</article-title>. <source>Exp. Neurobiol.</source> <volume>22</volume>, <fpage>149</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.5607/en.2013.22.3.149</pub-id><pub-id pub-id-type="pmid">24167410</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>H. M.</given-names></name> <name><surname>Ryu</surname> <given-names>J. R.</given-names></name> <name><surname>Jo</surname> <given-names>Y.</given-names></name> <name><surname>Seo</surname> <given-names>T. W.</given-names></name> <name><surname>Choi</surname> <given-names>Y. N.</given-names></name> <name><surname>Kim</surname> <given-names>J. H.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Drp1-Zip1 interaction regulates mitochondrial quality surveillance system</article-title>. <source>Mol. Cell</source> <volume>73</volume>, <fpage>e8.364</fpage>&#x02013;<lpage>e8.376</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2018.11.009</pub-id><pub-id pub-id-type="pmid">30581142</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Courchet</surname> <given-names>J.</given-names></name> <name><surname>Lewis</surname> <given-names>T. L.</given-names> <suffix>Jr.</suffix></name> <name><surname>Lee</surname> <given-names>S.</given-names></name> <name><surname>Courchet</surname> <given-names>V.</given-names></name> <name><surname>Liou</surname> <given-names>D. Y.</given-names></name> <name><surname>Aizawa</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Terminal axon branching is regulated by the LKB1-NUAK1 kinase pathway <italic>via</italic> presynaptic mitochondrial capture</article-title>. <source>Cell</source> <volume>153</volume>, <fpage>1510</fpage>&#x02013;<lpage>1525</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.05.021</pub-id><pub-id pub-id-type="pmid">23791179</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eckert</surname> <given-names>M. J.</given-names></name> <name><surname>Martin</surname> <given-names>M. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Trauma: spinal cord injury</article-title>. <source>Surg. Clin. North Am.</source> <volume>97</volume>, <fpage>1031</fpage>&#x02013;<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1016/j.suc.2017.06.008</pub-id><pub-id pub-id-type="pmid">28958356</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fawcett</surname> <given-names>J. W.</given-names></name> <name><surname>Verhaagen</surname> <given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Intrinsic determinants of axon regeneration</article-title>. <source>Dev. Neurobiol.</source> <volume>78</volume>, <fpage>890</fpage>&#x02013;<lpage>897</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22637</pub-id><pub-id pub-id-type="pmid">30345655</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fitch</surname> <given-names>M. T.</given-names></name> <name><surname>Silver</surname> <given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>CNS injury, glial scars and inflammation: inhibitory extracellular matrices and regeneration failure</article-title>. <source>Exp. Neurol.</source> <volume>209</volume>, <fpage>294</fpage>&#x02013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2007.05.014</pub-id><pub-id pub-id-type="pmid">17617407</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fonteriz</surname> <given-names>R.</given-names></name> <name><surname>Matesanz-Isabel</surname> <given-names>J.</given-names></name> <name><surname>Arias-Del-Val</surname> <given-names>J.</given-names></name> <name><surname>Alvarez-Illera</surname> <given-names>P.</given-names></name> <name><surname>Montero</surname> <given-names>M.</given-names></name> <name><surname>Alvarez</surname> <given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Modulation of calcium entry by mitochondria</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>898</volume>, <fpage>405</fpage>&#x02013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-26974-0_17</pub-id><pub-id pub-id-type="pmid">27161238</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname> <given-names>J. R.</given-names></name> <name><surname>Lackner</surname> <given-names>L. L.</given-names></name> <name><surname>West</surname> <given-names>M.</given-names></name> <name><surname>DiBenedetto</surname> <given-names>J. R.</given-names></name> <name><surname>Nunnari</surname> <given-names>J.</given-names></name> <name><surname>Voeltz</surname> <given-names>G. K.</given-names></name></person-group> (<year>2011</year>). <article-title>ER tubules mark sites of mitochondrial division</article-title>. <source>Science</source>, <volume>334</volume>, <fpage>358</fpage>&#x02013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1126/science.1207385</pub-id><pub-id pub-id-type="pmid">21885730</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname> <given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Myosin II activity is required for severing-induced axon retraction in <italic>in vitro</italic></article-title>. <source>Exp. Neurol.</source> <volume>189</volume>, <fpage>112</fpage>&#x02013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2004.05.019</pub-id><pub-id pub-id-type="pmid">15296841</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galloway</surname> <given-names>C. A.</given-names></name> <name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Yoon</surname> <given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial morphology-emerging role in bioenergetics</article-title>. <source>Free Radic. Biol. Med.</source> <volume>53</volume>, <fpage>2218</fpage>&#x02013;<lpage>2228</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.09.035</pub-id><pub-id pub-id-type="pmid">23032099</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galluzzi</surname> <given-names>L.</given-names></name> <name><surname>Bravo-San Pedro</surname> <given-names>J. M.</given-names></name> <name><surname>Blomgren</surname> <given-names>K.</given-names></name> <name><surname>Kroemer</surname> <given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Autophagy in acute brain injury</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>17</volume>, <fpage>467</fpage>&#x02013;<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.51</pub-id><pub-id pub-id-type="pmid">27256553</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Golpich</surname> <given-names>M.</given-names></name> <name><surname>Amini</surname> <given-names>E.</given-names></name> <name><surname>Mohamed</surname> <given-names>Z.</given-names></name> <name><surname>Azman Ali</surname> <given-names>R.</given-names></name> <name><surname>Mohamed Ibrahim</surname> <given-names>N.</given-names></name> <name><surname>Ahmadiani</surname> <given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment</article-title>. <source>CNS Neurosci. Ther.</source> <volume>23</volume>, <fpage>5</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12655</pub-id><pub-id pub-id-type="pmid">27873462</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gunter</surname> <given-names>K. K.</given-names></name> <name><surname>Gunter</surname> <given-names>T. E.</given-names></name></person-group> (<year>1994</year>). <article-title>Transport of calcium by mitochondria</article-title>. <source>J. Bioenerg. Biomembr.</source> <volume>26</volume>, <fpage>471</fpage>&#x02013;<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1007/BF00762732</pub-id><pub-id pub-id-type="pmid">7896763</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>S. M.</given-names></name> <name><surname>Baig</surname> <given-names>H. S.</given-names></name> <name><surname>Hammarlund</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitochondria localize to injured axons to support regeneration</article-title>. <source>Neuron</source> <volume>92</volume>, <fpage>1308</fpage>&#x02013;<lpage>1323</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.025</pub-id><pub-id pub-id-type="pmid">28009276</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>M.</given-names></name> <name><surname>Ding</surname> <given-names>Y.</given-names></name> <name><surname>Chu</surname> <given-names>C.</given-names></name> <name><surname>Tang</surname> <given-names>J.</given-names></name> <name><surname>Xiao</surname> <given-names>Q.</given-names></name> <name><surname>Luo</surname> <given-names>Z. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Autophagy induction stabilizes microtubules and promotes axon regeneration after spinal cord injury</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>113</volume>, <fpage>11324</fpage>&#x02013;<lpage>11329</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1611282113</pub-id><pub-id pub-id-type="pmid">27638205</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname> <given-names>C. E.</given-names></name></person-group> (<year>2017</year>). <article-title>A view from the ending: axonal dieback and regeneration following SCI</article-title>. <source>Neurosci. Lett.</source> <volume>652</volume>, <fpage>11</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2016.11.002</pub-id><pub-id pub-id-type="pmid">27825985</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname> <given-names>C. E.</given-names></name> <name><surname>Beattie</surname> <given-names>M. S.</given-names></name> <name><surname>Bresnahan</surname> <given-names>J. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat</article-title>. <source>Exp. Neurol.</source> <volume>171</volume>, <fpage>153</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1006/exnr.2001.7734</pub-id><pub-id pub-id-type="pmid">11520130</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>C.</given-names></name> <name><surname>Huang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Drp1-dependent mitochondrial fission plays critical roles in physiological and pathological progresses in mammals</article-title>. <source>Int. J. Mol. Sci.</source> <volume>18</volume>:<fpage>144</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18010144</pub-id><pub-id pub-id-type="pmid">28098754</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ingerman</surname> <given-names>E.</given-names></name> <name><surname>Perkins</surname> <given-names>E. M.</given-names></name> <name><surname>Marino</surname> <given-names>M.</given-names></name> <name><surname>Mears</surname> <given-names>J. A.</given-names></name> <name><surname>McCaffery</surname> <given-names>J. M.</given-names></name> <name><surname>Hinshaw</surname> <given-names>J. E.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Dnm1 forms spirals that are structurally tailored to fit mitochondria</article-title>. <source>J. Cell Biol.</source> <volume>170</volume>, <fpage>1021</fpage>&#x02013;<lpage>1027</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200506078</pub-id><pub-id pub-id-type="pmid">16186251</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname> <given-names>M. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders</article-title>. <source>Neurol. Res.</source> <volume>39</volume>, <fpage>73</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1080/01616412.2016.1251711</pub-id><pub-id pub-id-type="pmid">27809706</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>Y.</given-names></name> <name><surname>McEwen</surname> <given-names>M. L.</given-names></name> <name><surname>Nottingham</surname> <given-names>S. A.</given-names></name> <name><surname>Maragos</surname> <given-names>W. F.</given-names></name> <name><surname>Dragicevic</surname> <given-names>N. B.</given-names></name> <name><surname>Sullivan</surname> <given-names>P. G.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>The mitochondrial uncoupling agent 2,4-dinitrophenol improves mitochondrial function, attenuates oxidative damage and increases white matter sparing in the contused spinal cord</article-title>. <source>J. Neurotrauma</source> <volume>21</volume>, <fpage>1396</fpage>&#x02013;<lpage>1404</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2004.21.1396</pub-id><pub-id pub-id-type="pmid">15672630</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kageyama</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Z.</given-names></name> <name><surname>Sesaki</surname> <given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Mitochondrial division: molecular machinery and physiological functions</article-title>. <source>Curr. Opin. Cell Biol.</source> <volume>23</volume>, <fpage>427</fpage>&#x02013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceb.2011.04.009</pub-id><pub-id pub-id-type="pmid">21565481</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karbowski</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondria on guard: role of mitochondrial fusion and fission in the regulation of apoptosis</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>687</volume>, <fpage>131</fpage>&#x02013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4419-6706-0_8</pub-id><pub-id pub-id-type="pmid">20919642</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kasahara</surname> <given-names>A.</given-names></name> <name><surname>Scorrano</surname> <given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Mitochondria: from cell death executioners to regulators of cell differentiation</article-title>. <source>Trends Cell Biol.</source> <volume>24</volume>, <fpage>761</fpage>&#x02013;<lpage>770</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2014.08.005</pub-id><pub-id pub-id-type="pmid">25189346</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname> <given-names>Z. A.</given-names></name> <name><surname>Shokat</surname> <given-names>K. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Chemically targeting the PI3K family</article-title>. <source>Biochem. Soc. Trans.</source> <volume>35</volume>, <fpage>245</fpage>&#x02013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1042/BST0350245</pub-id><pub-id pub-id-type="pmid">17371250</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knoferle</surname> <given-names>J.</given-names></name> <name><surname>Koch</surname> <given-names>J. C.</given-names></name> <name><surname>Ostendorf</surname> <given-names>T.</given-names></name> <name><surname>Michel</surname> <given-names>U.</given-names></name> <name><surname>Planchamp</surname> <given-names>V.</given-names></name> <name><surname>Vutova</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Mechanisms of acute axonal degeneration in the optic nerve <italic>in vivo</italic></article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>107</volume>, <fpage>6064</fpage>&#x02013;<lpage>6069</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0909794107</pub-id><pub-id pub-id-type="pmid">20231460</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname> <given-names>D.</given-names></name> <name><surname>Yamori</surname> <given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Phosphatidylinositol 3-kinase inhibitors, promising drug candidates for cancer therapy</article-title>. <source>Cancer Sci.</source> <volume>99</volume>, <fpage>1734</fpage>&#x02013;<lpage>1740</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2008.00891.x</pub-id><pub-id pub-id-type="pmid">18616528</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korobova</surname> <given-names>F.</given-names></name> <name><surname>Ramabhadran</surname> <given-names>V.</given-names></name> <name><surname>Higgs</surname> <given-names>H. N.</given-names></name></person-group> (<year>2013</year>). <article-title>An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2</article-title>. <source>Science</source> <volume>339</volume>, <fpage>464</fpage>&#x02013;<lpage>467</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2008.00891.x</pub-id><pub-id pub-id-type="pmid">18616528</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krols</surname> <given-names>M.</given-names></name> <name><surname>van Isterdael</surname> <given-names>G.</given-names></name> <name><surname>Asselbergh</surname> <given-names>B.</given-names></name> <name><surname>Kremer</surname> <given-names>A.</given-names></name> <name><surname>Lippens</surname> <given-names>S.</given-names></name> <name><surname>Timmerman</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Mitochondria-associated membranes as hubs for neurodegeneration</article-title>. <source>Acta Neuropathol.</source> <volume>131</volume>, <fpage>505</fpage>&#x02013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-015-1528-7</pub-id><pub-id pub-id-type="pmid">26744348</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuroiwa</surname> <given-names>T.</given-names></name> <name><surname>Misumi</surname> <given-names>O.</given-names></name> <name><surname>Nishida</surname> <given-names>K.</given-names></name> <name><surname>Yagisawa</surname> <given-names>F.</given-names></name> <name><surname>Yoshida</surname> <given-names>Y.</given-names></name> <name><surname>Fujiwara</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Vesicle, mitochondrial, and plastid division machineries with emphasis on dynamin and electron-dense rings</article-title>. <source>Int. Rev. Cell Mol. Biol.</source> <volume>271</volume>, <fpage>97</fpage>&#x02013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/S1937-6448(08)01203-3</pub-id><pub-id pub-id-type="pmid">19081542</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lackner</surname> <given-names>L. L.</given-names></name> <name><surname>Nunnari</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Small molecule inhibitors of mitochondrial division, tools that translate basic biological research into medicine</article-title>. <source>Chem. Biol.</source> <volume>17</volume>, <fpage>578</fpage>&#x02013;<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2010.05.016</pub-id><pub-id pub-id-type="pmid">20609407</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname> <given-names>R. K.</given-names></name> <name><surname>Hilsabeck</surname> <given-names>T.</given-names></name> <name><surname>Rea</surname> <given-names>S. L.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of mitochondrial dysfunction in age-related diseases</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1847</volume>, <fpage>1387</fpage>&#x02013;<lpage>1400</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2015.05.021</pub-id><pub-id pub-id-type="pmid">26050974</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>G.</given-names></name> <name><surname>Cao</surname> <given-names>Y.</given-names></name> <name><surname>Shen</surname> <given-names>F.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Bai</surname> <given-names>L.</given-names></name> <name><surname>Guo</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Mdivi-1 inhibits astrocyte activation and astroglial scar formation and enhances axonal regeneration after spinal cord injury in rats</article-title>. <source>Front. Cell. Neurosci.</source> <volume>10</volume>:<fpage>241</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00241</pub-id><pub-id pub-id-type="pmid">27807407</pub-id></citation></ref>
<ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Keefe</surname> <given-names>K.</given-names></name> <name><surname>Tang</surname> <given-names>X.</given-names></name> <name><surname>Lin</surname> <given-names>S.</given-names></name> <name><surname>Smith</surname> <given-names>G. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration</article-title>. <source>PLoS One</source> <volume>9</volume>:<fpage>e87447</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0087447</pub-id><pub-id pub-id-type="pmid">24498323</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Y.</given-names></name> <name><surname>Hoffer</surname> <given-names>A.</given-names></name> <name><surname>Hoffer</surname> <given-names>B.</given-names></name> <name><surname>Qi</surname> <given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondria: a therapeutic target for Parkinson&#x02019;s disease</article-title>. <source>Int. J. Mol. Sci.</source> <volume>16</volume>, <fpage>20704</fpage>&#x02013;<lpage>20730</lpage>. <pub-id pub-id-type="doi">10.3390/ijms160920704</pub-id><pub-id pub-id-type="pmid">26340618</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname> <given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Mechanisms of neuronal homeostasis: autophagy in the axon</article-title>. <source>Brain Res.</source> <volume>1649</volume>, <fpage>143</fpage>&#x02013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2016.03.047</pub-id><pub-id pub-id-type="pmid">27038755</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname> <given-names>S.</given-names></name> <name><surname>Holzbaur</surname> <given-names>E. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Compartment-specific regulation of autophagy in primary neurons</article-title>. <source>J. Neurosci.</source> <volume>36</volume>, <fpage>5933</fpage>&#x02013;<lpage>5945</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4401-15.2016</pub-id><pub-id pub-id-type="pmid">27251616</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matlib</surname> <given-names>M. A.</given-names></name> <name><surname>Zhou</surname> <given-names>Z.</given-names></name> <name><surname>Knight</surname> <given-names>S.</given-names></name> <name><surname>Ahmed</surname> <given-names>S.</given-names></name> <name><surname>Choi</surname> <given-names>K. M.</given-names></name> <name><surname>Krause-Bauer</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria <italic>in vitro</italic> and <italic>in situ</italic> in single cardiac myocytes</article-title>. <source>J. Biol. Chem.</source> <volume>273</volume>, <fpage>10223</fpage>&#x02013;<lpage>10231</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.17.10223</pub-id><pub-id pub-id-type="pmid">9553073</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McEwen</surname> <given-names>M. L.</given-names></name> <name><surname>Sullivan</surname> <given-names>P. G.</given-names></name> <name><surname>Springer</surname> <given-names>J. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Pretreatment with the cyclosporin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats</article-title>. <source>J. Neurotrauma</source> <volume>24</volume>, <fpage>613</fpage>&#x02013;<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2006.9969</pub-id><pub-id pub-id-type="pmid">17439345</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mears</surname> <given-names>J. A.</given-names></name> <name><surname>Lackner</surname> <given-names>L. L.</given-names></name> <name><surname>Fang</surname> <given-names>S.</given-names></name> <name><surname>Ingerman</surname> <given-names>E.</given-names></name> <name><surname>Nunnari</surname> <given-names>J.</given-names></name> <name><surname>Hinshaw</surname> <given-names>J. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Conformational changes in Dnm1 support a contractile mechanism for mitochondrial fission</article-title>. <source>Struct. Mol. Biol.</source> <volume>18</volume>, <fpage>20</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.1949</pub-id><pub-id pub-id-type="pmid">21170049</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Molino</surname> <given-names>D.</given-names></name> <name><surname>Zemirli</surname> <given-names>N.</given-names></name> <name><surname>Codogno</surname> <given-names>P.</given-names></name> <name><surname>Morel</surname> <given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>The journey of the autophagosome through mammalian cell organelles and membranes</article-title>. <source>J. Mol. Biol.</source> <volume>429</volume>, <fpage>497</fpage>&#x02013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2016.12.013</pub-id><pub-id pub-id-type="pmid">27986571</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narayanareddy</surname> <given-names>B. R.</given-names></name> <name><surname>Vartiainen</surname> <given-names>S.</given-names></name> <name><surname>Hariri</surname> <given-names>N.</given-names></name> <name><surname>O&#x02019;Dowd</surname> <given-names>D. K.</given-names></name> <name><surname>Gross</surname> <given-names>S. P.</given-names></name></person-group> (<year>2014</year>). <article-title>A biophysical analysis of mitochondrial movement, differences between transport in neuronal cell bodies versus processes</article-title>. <source>Traffic</source> <volume>15</volume>, <fpage>762</fpage>&#x02013;<lpage>771</lpage>. <pub-id pub-id-type="doi">10.1111/tra.12171</pub-id><pub-id pub-id-type="pmid">24673933</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nasr</surname> <given-names>P.</given-names></name> <name><surname>Sullivan</surname> <given-names>P. G.</given-names></name> <name><surname>Smith</surname> <given-names>G. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Mitochondrial imaging in dorsal root ganglion neurons following the application of inducible adenoviral vector expressing two fluorescent proteins</article-title>. <source>J. Neurosci. Methods</source> <volume>172</volume>, <fpage>185</fpage>&#x02013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2008.04.023</pub-id><pub-id pub-id-type="pmid">18541307</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otera</surname> <given-names>H.</given-names></name> <name><surname>Ishihara</surname> <given-names>N.</given-names></name> <name><surname>Mihara</surname> <given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>New insights into the function and regulation of mitochondrial fission</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1833</volume>, <fpage>1256</fpage>&#x02013;<lpage>1268</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2013.02.002</pub-id><pub-id pub-id-type="pmid">23434681</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname> <given-names>A.</given-names></name> <name><surname>Merianda</surname> <given-names>T. T.</given-names></name> <name><surname>Twiss</surname> <given-names>J. L.</given-names></name> <name><surname>Gallo</surname> <given-names>G.</given-names></name></person-group> (<year>2020</year>). <article-title>Mechanism and role of the intra-axonal Calreticulin translation in response to axonal injury</article-title>. <source>Exp. Neurol.</source> <volume>323</volume>:<fpage>113072</fpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2019.113072</pub-id><pub-id pub-id-type="pmid">31669485</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname> <given-names>S. P.</given-names></name> <name><surname>Sullivan</surname> <given-names>P. G.</given-names></name> <name><surname>Lyttle</surname> <given-names>T. S.</given-names></name> <name><surname>Rabchevsky</surname> <given-names>A. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury</article-title>. <source>J. Neurochem.</source> <volume>114</volume>, <fpage>291</fpage>&#x02013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06764.x</pub-id><pub-id pub-id-type="pmid">20438613</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname> <given-names>S. P.</given-names></name> <name><surname>Sullivan</surname> <given-names>P. G.</given-names></name> <name><surname>Pandya</surname> <given-names>J. D.</given-names></name> <name><surname>Rabchevsky</surname> <given-names>A. G.</given-names></name></person-group> (<year>2009</year>). <article-title>Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury</article-title>. <source>J. Neurosci. Res.</source> <volume>87</volume>, <fpage>130</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.21814</pub-id><pub-id pub-id-type="pmid">18709657</pub-id></citation></ref>
<ref id="B64"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname> <given-names>G.</given-names></name> <name><surname>Charles</surname> <given-names>W.</given-names></name></person-group> (<year>2007</year>). <source>The Rat brain in Stereotaxic Coordinates</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</citation> </ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pitts</surname> <given-names>K. R.</given-names></name> <name><surname>Yoon</surname> <given-names>Y.</given-names></name> <name><surname>Krueger</surname> <given-names>E. W.</given-names></name> <name><surname>McNiven</surname> <given-names>M. A.</given-names></name></person-group> (<year>1999</year>). <article-title>The dynamin-like protein DLP1 is essential for normal distribution and morphology of the endoplasmic reticulum and mitochondria in mammalian cells</article-title>. <source>Mol. Biol. Cell</source> <volume>10</volume>, <fpage>4403</fpage>&#x02013;<lpage>4417</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.10.12.4403</pub-id><pub-id pub-id-type="pmid">10588666</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pradeep</surname> <given-names>H.</given-names></name> <name><surname>Sharma</surname> <given-names>B.</given-names></name> <name><surname>Rajanikant</surname> <given-names>G. K.</given-names></name></person-group> (<year>2014</year>). <article-title>Drp1 in ischemic neuronal death, an unusual suspect</article-title>. <source>Curr. Med. Chem.</source> <volume>21</volume>, <fpage>2183</fpage>&#x02013;<lpage>2189</lpage>. <pub-id pub-id-type="doi">10.2174/0929867321666131228203513</pub-id><pub-id pub-id-type="pmid">24372214</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname> <given-names>P. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Increased mitochondrial fission and neuronal dysfunction in Huntington&#x02019;s disease, implications for molecular inhibitors of excessive mitochondrial fission</article-title>. <source>Drug. Discov. Today</source> <volume>19</volume>, <fpage>951</fpage>&#x02013;<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2014.03.020</pub-id><pub-id pub-id-type="pmid">24681059</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname> <given-names>P. H.</given-names></name> <name><surname>Reddy</surname> <given-names>T. P.</given-names></name> <name><surname>Manczak</surname> <given-names>M.</given-names></name> <name><surname>Calkins</surname> <given-names>M. J.</given-names></name> <name><surname>Shirendeb</surname> <given-names>U.</given-names></name> <name><surname>Mao</surname> <given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases</article-title>. <source>Brain Res. Rev.</source> <volume>67</volume>, <fpage>103</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2010.11.004</pub-id><pub-id pub-id-type="pmid">21145355</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribas</surname> <given-names>V. T.</given-names></name> <name><surname>Lingor</surname> <given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Autophagy in degenerating axons following spinal cord injury, evidence for autophagosome biogenesis in retraction bulbs</article-title>. <source>Neural Regen. Res.</source> <volume>10</volume>, <fpage>198</fpage>&#x02013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.152367</pub-id><pub-id pub-id-type="pmid">25883612</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribas</surname> <given-names>V. T.</given-names></name> <name><surname>Schnepf</surname> <given-names>B.</given-names></name> <name><surname>Challagundla</surname> <given-names>M.</given-names></name> <name><surname>Koch</surname> <given-names>J. C.</given-names></name> <name><surname>Bahr</surname> <given-names>M.</given-names></name> <name><surname>Lingor</surname> <given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Early and sustained activation of autophagy in degenerating axons after spinal cord injury</article-title>. <source>Brain Pathol.</source> <volume>25</volume>, <fpage>157</fpage>&#x02013;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1111/bpa.12170</pub-id><pub-id pub-id-type="pmid">25040536</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sainath</surname> <given-names>R.</given-names></name> <name><surname>Ketschek</surname> <given-names>A.</given-names></name> <name><surname>Grandi</surname> <given-names>L.</given-names></name> <name><surname>Gallo</surname> <given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>CSPGs inhibit axon branching by impairing mitochondria-dependent regulation of actin dynamics and axonal translation</article-title>. <source>Dev. Neurobiol.</source> <volume>77</volume>, <fpage>454</fpage>&#x02013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22420</pub-id><pub-id pub-id-type="pmid">27429169</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saxton</surname> <given-names>W. M.</given-names></name> <name><surname>Hollenbeck</surname> <given-names>P. J.</given-names></name></person-group> (<year>2012</year>). <article-title>The axonal transport of mitochondria</article-title>. <source>J. Cell Sci.</source> <volume>125</volume>, <fpage>2095</fpage>&#x02013;<lpage>2104</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.053850</pub-id><pub-id pub-id-type="pmid">22619228</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname> <given-names>T. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondrial trafficking in neurons</article-title>. <source>Cold Spring Harb. Perspect. Biol.</source> <volume>5</volume>:<fpage>a011304</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a011304</pub-id><pub-id pub-id-type="pmid">23732472</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sesaki</surname> <given-names>H.</given-names></name> <name><surname>Adachi</surname> <given-names>Y.</given-names></name> <name><surname>Kageyama</surname> <given-names>Y.</given-names></name> <name><surname>Itoh</surname> <given-names>K.</given-names></name> <name><surname>Iijima</surname> <given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title><italic>in vivo</italic> functions of Drp1: lessons learned from yeast genetics and mouse knockouts</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1842</volume>, <fpage>1179</fpage>&#x02013;<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2013.11.024</pub-id><pub-id pub-id-type="pmid">24326103</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname> <given-names>Z. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Mitochondrial trafficking and anchoring in neurons: new insight and implications</article-title>. <source>J. Cell Biol.</source> <volume>204</volume>, <fpage>1087</fpage>&#x02013;<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201312123</pub-id><pub-id pub-id-type="pmid">24687278</pub-id></citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>G.</given-names></name> <name><surname>Gallo</surname> <given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>To mdivi-1 or not to mdivi-1, Is that the question</article-title>. <source>Dev. Neurobiol.</source> <volume>77</volume>, <fpage>1260</fpage>&#x02013;<lpage>1268</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22519</pub-id><pub-id pub-id-type="pmid">28842943</pub-id></citation></ref>
<ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spillane</surname> <given-names>M.</given-names></name> <name><surname>Ketschek</surname> <given-names>A.</given-names></name> <name><surname>Merianda</surname> <given-names>T. T.</given-names></name> <name><surname>Twiss</surname> <given-names>J. L.</given-names></name> <name><surname>Gallo</surname> <given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondria coordinate sites of axon branching through localized intra-axonal protein synthesis</article-title>. <source>Cell Rep.</source> <volume>5</volume>, <fpage>1564</fpage>&#x02013;<lpage>1575</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.11.022</pub-id><pub-id pub-id-type="pmid">24332852</pub-id></citation></ref>
<ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steketee</surname> <given-names>M. B.</given-names></name> <name><surname>Moysidis</surname> <given-names>S. N.</given-names></name> <name><surname>Weinstein</surname> <given-names>J. E.</given-names></name> <name><surname>Kreymerman</surname> <given-names>A.</given-names></name> <name><surname>Silva</surname> <given-names>J. P.</given-names></name> <name><surname>Iqbal</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Mitochondrial dynamics regulate growth cone motility, guidance and neurite growth rate in perinatal retinal ganglion cells in <italic>in vitro</italic></article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>53</volume>, <fpage>7402</fpage>&#x02013;<lpage>7411</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.12-10298</pub-id><pub-id pub-id-type="pmid">23049086</pub-id></citation></ref>
<ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>P. G.</given-names></name> <name><surname>Krishnamurthy</surname> <given-names>S.</given-names></name> <name><surname>Patel</surname> <given-names>S. P.</given-names></name> <name><surname>Pandya</surname> <given-names>J. D.</given-names></name> <name><surname>Rabchevsky</surname> <given-names>A. G.</given-names></name></person-group> (<year>2007</year>). <article-title>Temporal characterization of mitochondrial bioenergetics after spinal cord injury</article-title>. <source>J. Neurotrauma</source> <volume>24</volume>, <fpage>991</fpage>&#x02013;<lpage>999</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2006.0242</pub-id><pub-id pub-id-type="pmid">17600515</pub-id></citation></ref>
<ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname> <given-names>K.</given-names></name> <name><surname>Matsuki</surname> <given-names>N.</given-names></name> <name><surname>Koyama</surname> <given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>AMP-activated protein kinase mediates activity-dependent axon branching by recruiting mitochondria to axon</article-title>. <source>Dev. Neurobiol.</source> <volume>74</volume>, <fpage>557</fpage>&#x02013;<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22149</pub-id><pub-id pub-id-type="pmid">24218086</pub-id></citation></ref>
<ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>G. M.</given-names></name> <name><surname>Hayashi</surname> <given-names>T.</given-names></name> <name><surname>Chiu</surname> <given-names>S. L.</given-names></name> <name><surname>Chen</surname> <given-names>C. M.</given-names></name> <name><surname>Huganir</surname> <given-names>R. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Palmitoylation by DHHC5/8 targets GRIP1 to dendritic endosomes to regulate AMPA-R trafficking</article-title>. <source>Neuron</source> <volume>73</volume>, <fpage>482</fpage>&#x02013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.11.021</pub-id><pub-id pub-id-type="pmid">22325201</pub-id></citation></ref>
<ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanderluit</surname> <given-names>J. L.</given-names></name> <name><surname>McPhail</surname> <given-names>L. T.</given-names></name> <name><surname>Fernandes</surname> <given-names>K. J.</given-names></name> <name><surname>Kobayashi</surname> <given-names>N. R.</given-names></name> <name><surname>Tetzlaff</surname> <given-names>W.</given-names></name></person-group> (<year>2003</year>). <article-title><italic>In vivo</italic> application of mitochondrial pore inhibitors blocks the induction of apoptosis in axotomized neonatal facial motoneurons</article-title>. <source>Cell Death Differ.</source> <volume>10</volume>, <fpage>969</fpage>&#x02013;<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4401258</pub-id><pub-id pub-id-type="pmid">12934071</pub-id></citation></ref>
<ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname> <given-names>P.</given-names></name> <name><surname>Chierzi</surname> <given-names>S.</given-names></name> <name><surname>Codd</surname> <given-names>A. M.</given-names></name> <name><surname>Campbell</surname> <given-names>D. S.</given-names></name> <name><surname>Meyer</surname> <given-names>R. L.</given-names></name> <name><surname>Holt</surname> <given-names>C. E.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration</article-title>. <source>J. Neurosci.</source> <volume>25</volume>, <fpage>331</fpage>&#x02013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3073-04.2005</pub-id><pub-id pub-id-type="pmid">15647476</pub-id></citation></ref>
<ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winkle</surname> <given-names>C. C.</given-names></name> <name><surname>Taylor</surname> <given-names>K. L.</given-names></name> <name><surname>Dent</surname> <given-names>E. W.</given-names></name> <name><surname>Gallo</surname> <given-names>G.</given-names></name> <name><surname>Greif</surname> <given-names>K. F.</given-names></name> <name><surname>Gupton</surname> <given-names>S. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Beyond the cytoskeleton: the emerging role of organelles and membrane remodeling in the regulation of axon collateral branches</article-title>. <source>Dev. Neurobiol.</source> <volume>76</volume>, <fpage>1293</fpage>&#x02013;<lpage>1307</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22398</pub-id><pub-id pub-id-type="pmid">27112549</pub-id></citation></ref>
<ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Q.</given-names></name> <name><surname>Luo</surname> <given-names>C. L.</given-names></name> <name><surname>Tao</surname> <given-names>L. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Dynamin-related protein 1 (Drp1) mediating mitophagy contributes to the pathophysiology of nervous system diseases and brain injury</article-title>. <source>Histol. Histopathol.</source> <volume>32</volume>, <fpage>551</fpage>&#x02013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.14670/HH-11-841</pub-id><pub-id pub-id-type="pmid">27830583</pub-id></citation></ref>
<ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Q.</given-names></name> <name><surname>Xia</surname> <given-names>S. X.</given-names></name> <name><surname>Li</surname> <given-names>Q. Q.</given-names></name> <name><surname>Gao</surname> <given-names>Y.</given-names></name> <name><surname>Shen</surname> <given-names>X.</given-names></name> <name><surname>Ma</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Mitochondrial division inhibitor 1 (Mdivi-1) offers neuroprotection through diminishing cell death and improving functional outcome in a mouse model of traumatic brain injury</article-title>. <source>Brain Res.</source> <volume>1630</volume>, <fpage>134</fpage>&#x02013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2015.11.016</pub-id><pub-id pub-id-type="pmid">26596858</pub-id></citation></ref>
<ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>C. W.</given-names></name> <name><surname>Hang</surname> <given-names>L.</given-names></name> <name><surname>Yao</surname> <given-names>T. P.</given-names></name> <name><surname>Lim</surname> <given-names>K. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Parkin regulation and neurodegenerative disorders</article-title>. <source>Front. Aging Neurosci.</source> <volume>7</volume>:<fpage>248</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2015.00248</pub-id><pub-id pub-id-type="pmid">26793099</pub-id></citation></ref>
<ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>B.</given-names></name> <name><surname>Yu</surname> <given-names>P.</given-names></name> <name><surname>Lin</surname> <given-names>M. Y.</given-names></name> <name><surname>Sun</surname> <given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Facilitation of axon regeneration by enhancing mitochondrial transport and rescuing energy deficits</article-title>. <source>J. Cell Biol.</source> <volume>214</volume>, <fpage>103</fpage>&#x02013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201605101</pub-id><pub-id pub-id-type="pmid">27268498</pub-id></citation></ref>
<ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Z.</given-names></name> <name><surname>Matlib</surname> <given-names>M. A.</given-names></name> <name><surname>Bers</surname> <given-names>D. M.</given-names></name></person-group> (<year>1998</year>). <article-title>Cytosolic and mitochondrial Ca2+ signals in patch clamped mammalian ventricular myocytes</article-title>. <source>J. Physiol.</source> <volume>507</volume>, <fpage>379</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.1998.379bt.x</pub-id><pub-id pub-id-type="pmid">9518700</pub-id></citation></ref>
</ref-list>
</back>
</article>
